Variations of the coeliac artery and hepatic artery origins and their importance in selective internal radiation therapy. by Ho, Wai-chun. & Chinese University of Hong Kong Graduate School. Division of Surgical Sciences.
VARIATIONS OF THE COELIAC 
ARTERY AND HEPATIC ARTERY 
ORIGINS AND THEIR 
IMPORTANCE IN SELECTIVE 
INTERNAL RADIATION THERAPY 
by 
Ho Wai-chun (Student ID : 94186170) 
A thesis submitted 
To 
The Faculty of Medicine, Division of Surgical Science 
for the degree of 
Master of Philosophy 
The Chinese University of Hong Kong 
1998 
Approved by : Dr. Chan Sai Yu Michael (Supervisor) 
Date : December, 1997 
V y l ^ 
1¾ 1 6 I • ) l | 
UNIVERSITY / M j 
"VS^ J-IBRARY SYSTEM ^ ¾ ^ 
This thesis is dedicated to my daughter and my husband, 




166 HCC 110 HCC 
’ Seldinger X 





(44.6%) > (77.5%) + 
(93.1%) (42.0%) 
(94.6%) (99.3%) ° 72% 
28% ’ 55.4% 
° 
’ 
The Chinese University of Hong Kong 
Abstract 
VARIATIONS OF T H E COELIAC 
ARTERY AND HEPATIC ARTERY 
ORIGINS AND THEIR 
IMPORTANCE IN SELECTIVE 
INTERNAL RADIATION THERAPY 
by Ho Wai-chun 
Chairperson of the Supervisory Committee : Consultant Dr. Michael Chan 
Diagnostic Radiology and Organ Imaging Department 
Anatomic variations of the coeliac axis and its branches are known to be present 
in human as stated in anatomy textbooks. Trans-catheter Selective Internal 
Radiation therapy is a treatment of choice for the management of inoperable 
hepatocellular carcinoma. The success of this treatment procedure relies primarily 
on the superselective catheteri2ation of the hepatic artery (or arteries) for delivery 
of 90Yttrium microspheres and this is influenced by the vascular variations 
present in different subjects if any. This study was conducted from the point of 
view of a therapeutic interventionalist (instead of an anatomist) to determine the 
frequency of variants of the coeliac axis and its branches and presence of gender 
difference in Hong Kong Chinese. The influence of anomalies upon 90Yttrium 
Selective Internal Radiation therapy and the possibility that arterial variation may 
be a predisposing factor to hepatocellular carcinoma was also studied. 
276 subjects were recruited with 166 subjects confirmed as having HCC and 110 
subjects without HCC. All arteriograms were performed by the same radiologist 
using the Philips V3000 Digital Subtraction Angiographic (DSA) system. 
Seldinger technique was employed and catherization was monitored under 
i 
fluoroscopic control. Serial arteriograms with predefined filming sequences were 
obtained. All resultant arteriograms were viewed on the viewing console and the 
arterial patterns were analysed. Origins of the coeliac axis and its branches were 
recorded and the percentage frequency were later calculated. The vessels studied 
included coeliac axis, common hepatic artery, proper hepatic artery, right hepatic 
artery, middle hepatic artery, left hepatic artery, gastroduodenal artery, right gastric 
artery, left gastric artery and splenic artery. 
Variations of the coeliac axis and its branches in Hong Kong Chinese were 
documentated and their corresponding percentages charted. Highest occurrence 
of individual vessel origin was in conformity with the classical pattern mentioned 
in anatomy textbook. Predominant vessel origins were coeliac axis from aorta 
(98.6%), common hepatic from coeliac axis (97.8%), proper hepatic from 
common hepatic artery (80.4%), right hepatic from proper hepatic artery (80.4%), 
middle hepatic from right hepatic artery (44.6%) or from left hepatic artery 
(32.6%), left hepatic from proper hepatic artery (77.5%), gastroduodenal from 
common hepatic artery (93.1%), right gastric from proper hepatic artery (42.0%), 
left gastric from coeliac axis (94.6%) and splenic from coeliac axis (99.3%). 72 % 
of subjects had at least one variant and 28% had none. 55.4% of subjects had the 
liver arterial supply presented as the classical pattern. No gender difference was 
noted in the arterial variations. The influence of the variations of the coeliac and 
its branches upon the technique of 90Yttrium microspheres delivery is extensively 
discussed and illustrated. 
In Hong Kong Chinese, coeliac axis and its branches did present a spectrum of 
variations which required conscientious modifications during Selective Internal 
Radiation therapy for hepatocellular carcinoma. This therapeutic procedure was 
feasible in every individual needing it despite the presence of arterial variation. 
Apparently, arterial variations were more extensive in Europeans than in Hong 
Kong Chinese. Gender did not predispose to particular arterial patterns and 
ii 
presence of arterial variation was not a pre-disposing factor for hepatocellular 
carcinoma. 
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Chap t e r 1 
INTRODUCTION 
Hepatocellular carcinoma presents an enormously difficult clinical problem. 
Patients with hepatoma represent a rather special physiologic situation - perhaps 
more special than any other adult malignancy. Hepatomas often arise in the 
background of chronic liver disease - such as post-necrotic cirrhosis or chronic 
hepatitis. Surgery is the preferred treatment when the tumour is confined to a 
resectable segment or lobe. Its prognosis is extremely poor with a median 
survival of less than three months (H.K. Cancer Registry, 1993). Most cases are 
considered inoperable at the time of diagnosis due to extreme tumour extension 
and accompanying advanced cirrhosis. Disease localised to one lobe of the liver 
without any major vascular involvement or extrahepatic disease is usually 
resectable provided the liver reserve is good. Portal vein or hepatic vein invasion 
precludes the patient from surgery. (Leung Wai-Tong, 1995) About 90% of 
patients are not suitable for resection at the time of presentation (Shiu et a/., 1990). 
At the Joint Hepatoma Clinic of the Prince of Wales Hospital of Hong Kong, 
locoregional treatment using intra-hepatic-arterial chemotherapy, 
chemoembolisation and selective internal radiation with Lipiodol-131I or 90Y 
microshperes is currently employed for the treatment of inoperable HCC (Leung 
et al., 1994). At present, studies show that intraarterial 90Y microspheres given 
through an angiographic catheter is a feasible treatment for non-resectable HCC 
(W.Y.Lau et al., In press). 
Percutaneous trans-catheter 90Y-SIR treatment is a hybrid of the advancement 
in at least three areas, viz. angiographic technique, digital imaging technique and 
radiation oncology. The first documented arteriogram was performed in January 
of 1896. Through decades of improvement till 1953, Sven Ivar Seldinger of 
Introduction 
Sweden introduced the Seldinger technique of inserting a catheter into a blood 
vessel through a skin puncture. This marked the birth of modern angiography 
and interventional radiology (W.C.G. Peh, 1996 p.90) . In the 1980s, digital 
vascular imaging came into routine clinical use and with digital subtraction, 
maximum information can be extracted with elimination of the uninformative 
bony structures (W.C.G. Peh, 1996 p.88). Furthermore, real time high resolution 
fluoroscopy is a prerequisite to every interventional procedure, especially vascular 
interventional procedures. Rontgen's discovery of x rays in 1895 marked a new 
era in the medical field. X rays were used not only in diagnosis, they had 
applications in therapy as well. Shortly after the discovery of x rays, the first 
cancer treatment using x rays was reported in January of 1896 (W.C.G. Peh, 1996 
p.93). In the beginning of the twentieth century, radionuclides started to be used 
in cancer treatment. In the nineteen eighties, 90-Yittrium shed light to the 
treatment of the difficult tumour, hepatocellular carcinoma. In the early nineties, 
90-Yittrium microspheres were infused under fluoroscopy into the hepatic artery 
through an arterial porta-cath which was implanted during laparotomy (W.Y.Lau 
et al., 1994). In the mid nineties, trans-catheter treatment came to light because of 
technical advances in digital vascular imaging and vast improvement in catheter 
and guidewire technology. Also, the partition model has made Selective Internal 
Radiation therapy using 90-Yittrium microspheres safe and repeatable without 
laparotomy (S.Ho et al., 1997). 
The first step to successful trans-catheter Selective Internal Radiation 
treatment is one or more successful superselective catheterizations. Finding a 
good match between the selective catheter, the guidewire, and the vascular 
anatomy is the secret to successful superselective catheterization (Abrams, 1997, 
p. 155). Thus, arterial supply to the liver and any variants of the coeliac axis and 
its branches dictate the catheter placement for infusion of the 90Y microspheres 
and any necessary modifications during the 90-Yttrium Selective Internal 
Radiation treatment procedure. 
1-2 
Introduction 
Constituents of the coeliac axis and the upper segment of the superior 
mesenteric artery vary to such an extent that any classification of the axis is purely 
arbitrary and, accordingly, will differ with the viewpoint adopted by the author 
(Michels, 1955). The fact that arterial variations do exist was well documented. 
Haller, the great Swiss physiologist, emphasized 200 years ago the need for an 
atlas on the variational anatomy of the coeliac artery which supplies the 
abdominal organs. Thompson, of Canada (1933), expressed that if anatomic 
variations are worth knowing at all, they are worth knowing as accurately as 
possible. The most recent large scale study of the abdominal arterial variations 
was done by Michels in 1955. In the study, 200 cadavers were dissected and 
statistical analysis of the blood supply of the liver and gallbladder was done. In 
the 1966, Michels made another publication based on the previous 200 
dissections on the description of ten basic types of hepatic blood supply, the 
sources of singly and dual cystic arteries and of aberrant left and right hepatics 
and twenty-six collateral pathways to the liver (Michels, 1966). The studies were 
based on dissections of cadavers and from the anatomist's or the surgeon's point 
of view. 
In this study, the classification is from the point of view of a radiological 
interventionist who delivers the 90-Yittrium microspheres mixture to the 
hepatocellular carcinoma. The vessels studied are the coeliac axis, common 
hepatic artery, proper hepatic artery, right hepatic artery, middle hepatic artery, 
left hepatic artery, gastroduodenal artery, right gastric artery, left gastric artery, and 
the splenic artery. The origins of these vessels dictate the catheter tip placement 
for delivering the radioactive microspheres mixture to the tumour and at the same 
time preventing gastritis caused by passage of radioactive microspheres into the 
vessels supplying the stomach and duodenum. 
1-3 
Introduction 
In this thesis, after the introductory chapter, some basic principles are 
described in chapter two. These include anatomy and blood supply of the liver, 
normal and variant arterial anatomy of the coeliac axis, management of 
hepatocellular carcinoma and knowledge of the 90-Yttrium Selective Internal 
Radiation therapy for inoperable hepatocellular carcinoma. The classification 
method used in this study are defined in chapter three. The objectives of this 
study are then stated in chapter four, and the materials and methods are described 
in chapter five. In chapter six, the results are presented with the bar charts 
showing the frequency of the vessel origins, and arteriograms are illustrated. 
Chapter seven is on result analysis, and the influence of the arterial variants on the 
90-Yttrium Selective Internal Radiation treatment procedure is discussed. A final 




2.1 The liver 
2.1.1 A vital organ 
The liver is the largest organ in the body, weighing 1.2-1.5 kilogram (Macleod 
J, 1978). It occupies most of the right upper quadrant and epigastrium of the 
abdominal cavity (figure 2.01). 
Although the liver is considered to be a structural part of the digestive system, 
it performs many functions not directly concerned with digestion. It has 
phagocytic cells (Kupffer's cells) which engulf bacteria and other foreign particles 
in the blood. Kupffer's cells are also very efficient at removing immune 
complexes from the blood. Thus the liver is capable of preventing undesirable 
immunological reactions. It is the most important organ for maintenance of 
normal blood glucose concentration. The synthesis of many proteins with their 
export into the blood is a major function of the liver. The liver is also responsible 
for amino-acid metabolism prior to their interconversion and oxidation. Urea 
synthesis occurs solely in the liver. The liver is quantitatively the most important 
organ for drug metabolism and it metabolizes about 90 percent of all alcohol 
ingested. A major digestive function of the liver involves the production and 
secretion of bile. 
The liver actually exerts a number of important influences on nutrition : its 
bile secretion is essential in the digestion of fat, it stores glycogen, it stores 
vitamin A, B12’ D, E, and K, and it is involved in the metabolism of proteins, 
fats, and carbohydrates. 
Basic principle The liver,segmental anatomy 
Apart from the above mentioned, the liver is the main heat producing organ of 
the body due to its high metabolic rate. Other functions of the liver include 
blood cell formation (hematopoiesis), coagulation, and detoxification. 
2.1.2 Segmental anatomy of the liver 
The liver has a right lobe and a left lobe. The right lobe is larger, and it 
contains the quadrate and the caudate lobe(Macleod J, 1978). A line from a point 
to the left of the gallbladder fossa anteriorly and inferiorly to the vena cava 
dorsally divides the liver into anatomic right and left lobes. No visible anatomic 
landmark helps to distinguish right from left lobes. The umbilical fissure and the 
falciform ligament divide the left lobe into medial and lateral segments, The right 
lobe contains anterior and posterior segments, although there are no surface 
markings to delineate the right lobe segments (R. Scott Jones, 1990). (Figure 2.02, 
figure 2.03) 
The segmental anatomy of the liver is based on the intrahepatic distribution of 
the portal trinity (portal vein, bile duct, hepatic artery) and its divisions. There are 
eight segments and segment I is the caudate lobe of the liver. The caudate lobe is 
an autonomous segment receiving branches of the portal trinity from both right 
and left sides (Bernard, Jamieson, Starzl, 1993). The other segments, segment II 
to segment VIII are shown schematically in figure 2.04. 
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Basic principle The liver 
Figure 2.01 The position of the liver in the abdominal cavity. 
(From Foundations of Anatomy and Vhysiolo^ bj Ross <& Wilson) 
n … M 
1 i / ‘ \ ^ i 
ER c t 
TRANSVERSE \ ^ V / • \ :1 
C C I O N " " + \ / 
AsamiHG^Ll ^ ^ ^ 1 $ C v L I 
\ HTrKTh 
2-3 
Basic principle The liver 
Figure 2.02 Ventral view of the liver 
(From Atlas ofUver and Miliary Surgery by K Scott Jones) 
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Figure 2.03 Dorsal view of the liver 
(From Atlas oJUverand Miary Surgery by K Scott]ones) 
‘ 
2-4 
Basic principle The liver,segmental anatomy 
Figure 2.04 Segments of the liver. 
(From Modern Operative Techniques in Uver Surgery bj Launois, Jameson (& Standi) 
. 
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2.1.3 Vascular anatomy of the liver 
Much of the importance of the liver is largely due to its dual blood supply 
derived from the gut as well as from the systemic circulation. About 75% of the 
blood supply to the liver is from the portal veins and the remaining 25% from the 
hepatic arteries. Venous drainage is via the hepatic veins which drain directly into 
the inferior vena cava. (Ross & Wilson, 1973) 
Histologically, the liver parenchyma is made up of small polyhedral lobules 
which are the functional units of the liver. (See Appendix I for drawings of 
histological anatomy) Each lobule is approximately 1 mm in diameter and 
consists of columns of liver cells and sinusoids with a central vein. Pervading the 
liver are two separate systems of pipelines : the portal tracts and the hepatic 
central canals. The portal tract lies between the lobules and contain a portal vein 
radicle, hepatic arteriole, and bile duct. The lymphatic channels are also located in 
the portal tracts. The hepatic central canals contain radicles of the hepatic vein 
into which the sinusoids drain arterial and portal venous blood. 
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2.2 Blood supply of the liver 
2.2.1 Arterial supply 
The hepatic arterial supply has many variations. Details of the common 
variations are discussed in the next section. The classical presentation is shown in 
figure 2.05 with the common hepatic artery arising from the coeliac axis. The 
common hepatic artery, after giving off the gastroduodenal artery, continues as 
the proper hepatic artery. The proper hepatic artery branches into the right and 
left hepatic artery and this branching is either intrahepatic or extrahepatic. The 
middle hepatic artery arises from either the right or left hepatic artery. 
Sometimes, there are multiple small middle hepatic arteries. 
2.2.2 Portal supply 
The portal vein carries splanchic blood to the liver and is formed by the 
confluence of the splenic vein and superior mesenteric vein. The confluence is 
extrahepatic. The portal vein divides into the right and left portal veins. The right 
portal branch divides into an anterior and a posterior branch and each of these 
divides into an ascending and a descending branch. The left portal branch also 
divides into an ascending and a descending branch. Figure 2.06 and figure 2.07 
are schematic diagrams of the portal system. 
2.2.3 Venous drainage 
Generally the hepatic venous drainage consists of left, middle, and right 
hepatic veins which enter the inferior vena cava in the high subdiaphragmatic 
portion of the liver (figure 2.08) 
2-7 
Basic principle classical presentation 
Figure 2.05 Classicalpresentation of the arterial supply {from the coeliac axis) to the liver 
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Fimre 2.06 Schematic diagram of the portal veins. 
(From foundations of Anatomy and Phjsiolog)! by Ross <& Wilson) 
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Fimre 2.07 Schematic diagram of the portal veins in relation to the segments. 
(From Modern Operative Techniques in Uver Surgery bj Launois, Jameson (& Starzl) 
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Fimre 2.08 The major hepatic veins. 
(From Modern Operative Techniques in Liver Surgery by Launois, Jameson <& Star\l) 
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2.3 Normal arterial anatomy of the coeliac axis 
In this section, the 'normal' arterial anatomy of the coeliac axis is described. 
However, this 'normality' is only found in 65 to 75 per cent of all individuals, as 
cited from classical anatomy textbooks. Thus it is referred to as the classical 
presentation. 
2.3.1 Development of the abdominal aorta: 
The branches of the abdominal aorta are divided into three groups: dorsal, 
lateral and ventral (figure 2.09). 
The dorsal branches are segmental. During development, the lumbar arteries 
I - IV remain segmental arteries while the 5th artery forms the common iliac 
artery. 
The lateral branches supply the kidneys and the genital organs. 
The ventral branches develop initially as paired vessels. The arteries to the gut 
merge early to form the coeliac axis, superior mesenteric and inferior mesenteric 
arteries. The umbilical arteries are also ventral branches and longitudinal 
anastomoses with L5 artery develop. The initial origins from the aorta disappear. 
After birth, their distal parts form the lateral umbilical ligaments. 
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Fimre 2.09 Branches of the abdominal aorta 
(From Arterial variations in man. Classification andfrequency by Munchen) 
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2.3.2 Coeliac axis 
The coeliac axis arises anteriorly from the aorta between the twelfth thoracic 
vertebral body and the first lumbar vertebral body. The origin is usually slightly to 
the left of the mid line. The classical pattern is that of the ‘complete coeliac axis' 
and its main branches include the gastric artery, the common hepatic artery and 
the splenic artery . The true trifurcation type (figure 2.10) accounts for only 25 per 
cent of all individuals. Another 'textbook' pattern (figure 2.11) accounts for 49 
per cent of all individuals in which the coeliac axis gives rise to the left gastric 
artery as a side branch, and then divides more distally into the common hepatic 
artery and the splenic artery. (Lippert & Pabst, 1985) 
Fipujv 2.10 Complete coeliac axis - Figure 2.11 Complete coeliac axis -
true trification (25%) LG as side branch of coeliac axis (49%) 
(From Arterial variations in man. Classification and frequency bj Lippert & PabstJ 
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2.3.3 Coeliac artery 
The coeliac artery is the first portion of the coeliac axis. It averages 1 to 2 
centimeters in length. 
2.3.4 Left gastric artery 
The left gastric artery arises from the coeliac axis in about 90 per cent of the 
population. It is commonly the first major branch of the coeliac axis (figure 2.11). 
It is the smallest of the three major branches. It usually courses along the lesser 
curvature of the stomach to anastomose with the right gastric artery. 
2.3.5 Common hepatic artery 
The common hepatic artery is one of the major branches of the coeliac axis. 
Normally it is slightly smaller than the splenic artery and it courses to the right. 
After giving off the gastroduodenal artery, the hepatic trunk is refered to as the 
proper hepatic artery. The proper hepatic artery then divides into the right and 
left hepatic arteries. The middle hepatic artery may arise from the right or left 
hepatic artery. This classical pattern constitutes about 50 per cent of the 
population (figure 2.12). 
The gastroduodenal artery almost always arises before the common hepatic 
divides into the hepatic branches (figure 2.12). 
The right gastric artery arises from the proper hepatic artery in 50 per cent of 
the population (figure 2.13). (Lippert & Pabst 1985) 
2.3.6 Splenic attery 
The splenic artery arises from the coeliac axis and courses to the left of the 
body (figure 2.10, figure 2.11). It is usually the largest and the most tortuous 
branch of the coeliac axis. 
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Fimre 2.12 Arterial blood supply of the liver from coeliac axis only 
-CH is a branch of the coeliac axis (50%) 
(From Arterial variations in man. Classification and frequency by Uppert <& Pabst) 
CH 
RH / I Coeliac 
GD 
2-15 
Basic principle Normal Coeliac & its branches 
Figure 2.13 'Noma/' origin of the right gastric artery -from PH (50%) 
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2.4 Common variations of the coeliac axis 
2.4.1 Hepatic arterial supply 
In about 55% of the population, the 'classical' hepatic arterial branching 
pattern is seen with the entire right, left, and middle hepatic arteries originating 
from the common hepatic artery (Saadoon, 1991). The proper hepatic artery is a 
continuation of the common hepatic artery and it divides into the right and left 
hepatic arteries. The middle hepatic artery may arise from the right or left hepatic 
artery. (Figure 2.14) 
Other vessels in close relation with the hepatic arterial supply are the 
gastroduodenal artery and the right gastric artery. The gastroduodenal artery 
originates from the common hepatic artery in about 75% of the population and 
arises almost always prior to the division of the proper hepatic artery into right 
and left branches (Saadoon, 1991). (Figure 2.14) The right gastric artery branches 
from the proper hepatic artery in 40% of the population (Saadoon, 1991). (Figure 
2.14) Both these vessels supply the upper gastrointestinal tract and the pancreas. 
Their origins are especially important when performing endovascular intervention 
procedure of the liver 
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Fimre 2.14 Hepatic arterial supply from the proper hepatic artery. 
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2.4.2 Normal variations of the hepatic arterial supply 
Michels (1955) has pointed out that forty to fifty percent of individuals have 
significant anatomic variations in the coeliac and superior mesenteric arteries. 
These variations occur most often at the origins of the hepatic artery. The 
common variations of the coeliac axis and superior mesenteric artery can be 
explained by persistence of some or all of the primitive ventral anastomoses of 
the vitelline arteries and associated variations in the preservation of the tenth and 
thirteenth vitelline roots (Reuter, Redmann & Cho, 1986).(Figure 2.15, figure 
2.16) 
In understanding arterial variations one has to bear in mind the concept that all 
variations are due to preferential flow in normal arterial structures. During 
development, some arterial pathways develop and some involute. 
Embryologically, the liver bud derives from the duodenum. As the liver develops, 
the hepatic artery flow increases. The liver can then be considered as a collateral 
of the gastroduodenal artery. Because of the presence of a marginal vessel parallel 
to the digestive tube between the inferior diaphragmatic, left gastric, 
gastroduodenal, and superior mesenteric arteries, it is possible that the hepatic 
artery can haemodynamically derive from any of these vessels (figure 2.17). Table 
2.01 lists some of the common variations which are important to the 
endovascular treatment of hepatic lesions. 
(see Appendix II for embryology) 
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Figure 2.15 The primitive vascular supply - All segmental arteries and a ventral anastomosis 
are present 
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Figure 2.17 Schematic showing vascularising state of the digestive tube embryoloQicalh 
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Table 2.01 Variant anatomy of the hepatic arterial supply 
Type Incidence Illustration 
Coeliacomesenteric trunk (Coeliac axis and superior < 1% Figure 2.18 
mesenteric artery have same origin.) 
Common hepatic artery from aorta 2% Figure 2.19 
Common hepatic artery from superior mesenteric artery 2.5% Figure 2.20 
Right hepatic artery from superior mesenteric artery 14-18% 
Replaced right hepatic 10-12% Figure 2.21 
Accessory right hepatic 4- 6% Figure 2.22 
Left hepatic artery from the left gastric artery 12% 
Accessory left hepatic from the left gastric artery 6% Figure 2.23 
Figure 2.18 Coeliacomesenteric trunk Figure 2.19 CH from Aorta 
(From Modern Operative Techniques in Uver Surgery bj Launois, Jameson (& Star\l) 
Coeliac L G LG ^ 
SMA ) 
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Fimre 2.20 CHfmmSMA Fimre 2.21 RHfrvm SIVLA 
(From Modern Operative Techniques in Liver Surgery by Launois, Jameson <& Star^l) 
_ _ 
Fimre 2.22 ACC RH fmmSMA F— 2.23 ACC LHfrvmLG 
(From Modern Operative Techniques in Liver Surgery bj LMunois, Jameson <& Star^l) 
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2.5 Previous classification of coeliac anomalies 
In this section, Michels' classification is described. 
2.51 Types of coeliac axis 
• Type I. Hepatolienogastric Trunk 
This type of coeliac trunk has the left gastric, the splenic and a hepatic 
artery - either the common hepatic or its right or left branch. (Figure 
2.24) 
• Type II. Hepatolienal Trunk 
In this type, the hepatic and the splenic arise from a common coeliac 
trunk. The left gastric is displaced, i.e., arises separately from the aorta, 
the splenic or the hepatic. (Figure 2.25) 
• Type III. Hepatolienomesenteric Trunk 
In this type, the sole coeliac component remaining in situ is the left 
gastric, which arises separately from the aorta. The hepatic, the splenic 
and the superior mesenteric arise from a common trunk derived from 
the aorta. (Figure 2.26) 
• Type IV. Hepatogastric Trunk 
In this type, the left gastric and the hepatic arise from a common trunk 
at the coeliac site and the splenic arises from the superior mesenteric. 
(Figure 2.27) 
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• Type V. Lienogastric Trunk 
In this type of coeliac trunk, the splenic and the left gastric arise from a 
common trunk, and the hepatic artery is replaced from another source. 
(Figure 2.28) 
• Type VI. Coeliacomesenteric Trunk 
Here, the four regional arteries (hepatic, left gastric, splenic and superior 
mesenteric) arise from the aorta by a common trunk. 
• Type VII. Coeliacocolic Trunk 
In this type, the middle colic or the left colic takes origin from the 
coeliac instead of from the superior mesenteric. (Figure 2.29) 
(See Appendix III for the occurrence percentages of the different types 
of coeliac axis, by Michels' study) 
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Figure 2.24 Hepatolienomstric Trunk 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive Atlas 
by N^i. Michels) 
Figure 2.25 Hepatorenal Trunk 
(^rom Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive Atlas 
by i\L4. Michels) 
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Figure 2.26 The hepatic the splenic and the SMA arise from a common trunk from the aorta 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive Atlas 
by AL4 Michels) 
, , 1 
Vimre 2.27 The left gastric and the hepatic from a common trunk at the coeliac, SA fr SMA 
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Fimre 2.28 The splenic and the left gastric arise from a common trunk at the coeliac the 
hepatic is replaced from other source 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive Atlas 
by N, A. Miche/s) 
Figure 2.29 The middle colic artery takes omin from the coeliac 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive Atlas 
bj> N.A. Michels) 
} 
t . 
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2.52 Basic types of the hepatic arterial blood supply 
• Type I. 
This is the textbook type, where the coeliacal hepatic supplies the right, 
the left and the middle hepatics. 
• Type II 
The coeliacal hepatic supplies the right and the middle hepatics and the 
left hepatic replaced from the left gastric. 
• Type III 
The coeliacal hepatic supplies the left and the middle hepatics while the 
right hepatic is replaced from the superior mesenteric. 
Type IV 
The coeliacal hepatic supplies the middle hepatic only. The right hepatic 
is replaced from the coeliac or the superior mesenteric, and the left 
hepatic is replaced from the left gastric. 
• Type V 
The coeliacal hepatic supplies the right, the left and the middle hepatics. 
There is an accessory left hepatic from the left gastric 
• Type VI 
The coeliacal hepatic supplies the right, the left and the middle hepatics. 
There is an accessory right hepatic from the superior mesenteric. 
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• Type VII 
The coeliacal hepatic supplies the right, the left and the middle hepatics. 
In addition, there is an accessory right hepatic from the superior 
mesenteric and an accessory left hepatic from the left gastric. 
• Type VIII 
This type is a combination of two patterns: 
(1) There is a replaced right hepatic (i.e. not from the coeliacal hepatic 
trunk) and an accessory left hepatic. 
(ii) There is a replaced left hepatic (i.e. not from the coeliacal hepatic 
trunk) and an accessory right hepatic. 
• Type IX 
The entire hepatic trunk is derived from the superior mesenteric with 
the coeliacal hepatic absent. 
• Type X 
The entire hepatic trunk is derived from the left gastric when the 
coeliacal hepatic is absent. 
(See Appendix IV for the occurrence percentages of the different types 
of hepatic arterial supply, by Michels' study) 
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2.6 Knowledge of arterial anomaly in relation to surgery 
2.6.1 Preparation for liver resection 
The surgeon must answer three important questions when evaluating a patient 
for liver surgery. The questions are : 
1. Can the lesion be removed completely without damage to vital structures? 
2. Will the patient's general health allow the patient to survive a major 
operation? 
3. Does the patient possess enough liver reserve and capacity for liver 
regeneration to permit removal of the amount of liver tissue required to 
eliminate the disease? 
In many cases, arteriography, venography, and cholangiography can aid in the 
evaluation of anatomic resectability. In the context of this study, we are interested 
in the arteriography and the information it provides, in relation to liver surgery, 
about the vascular map and any anomaly present in the patient. 
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2.6.2 Attention with regard to hepatic arteries 
For liver resection, attention with regard to hepatic arteries are : 
• At the hilum, after opening the Calot's triangle, while palpating the 
hepatoduodenal ligament for any portal nodal spread of tumor it is 
necessary to make sure whether there are any aberrant right hepatic 
arteries arising from the superior mesenteric artery. (R. Scott Jones, 
1990) 
• During hepatic artery ligation in right hepatectomy, the right hepatic 
artery should be preserved as long as possible and tied extremely close 
to the parenchyma, because vascular supply of the common hepatic 
duct is mainly derived from the right hepatic artery. (R. Scott Jones, 
1990) 
• Accessory left hepatic artery may arise from the left gastric artery. 
Ligation of this vessel is required in left hepatectomy. (R. Scott Jones, 
1990) 
• For liver trauma, selective ligation of the hepatic artery is indicated 
when intrahepatic ligation or suture has failed to control hepatic arterial 
haemorrhage. (Launois, Jamieson, and Starzl, 1993) 
• During hepatic lobectomy the surgical team must avoid injury of the 
vessels and ducts to the lobe that must remain. (R. Scott Jones 1990) 
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2.7 Trans-catheter treatment of HCC 
2.7.1 Treatment of HCC 
Although sutgery is the preferred treatment for HCC, a mortality rate as high 
as 33% is associated with certain hepatic resections. (Melvin E. Clouse, 1983) 
2.7.1.1 Intravenous chemotherapy 
In the early eighties, intravenous chemotherapy had been attempted. The 
drugs used included Adriamycin (ADM, doxorubicin), 5-fluorouracil (5-FU) and 
Methyl-CCNU (MeCCNU). These drugs were used either as a single agent 
therapy or combination drug programs, but these attempts to palliate hepatoma 
patients had generally resulted in more frustration than benefit. Furthermore, 
when the toxicity of treatment is borne in mind it is clear that none of the 
intravenous chemo-treatments can be recommended as a standard treatment 
approach. (G. Falkson & J.M. MacINTYRE et al, 1984) 
2.7.1.2 Conventional radiotherapy 
Conventional radiotherapy was of “ no benefit “ for patients with HCC. This 
conclusion was based on the use of 2,000 to 3,000 rad as a single modality. 
Hepatoma is too virulent a disease for this modest radiation dose to be effective. 
However, the use of larger dose/fraction external radiation therapy is an effective 
means of symptom palliation. From M. A. Friedman's study, data showed that 
doses of 2,500 to 3,500 rad could be tolerated without undue risk of radiation 
hepatitis, but studies also showed that external radiation alone provided only 
temporary, modest benefits, at best. (Michael A. Friedman, 1983) 
2.7.1.3 Internal irradiation with radioiinmunoglobulins 
Internal irradiation with radioimmunoglobulins is another form of 
radiotherapy for HCC. With the development of various monoclonal antibodies 
such as antiferritin and anti-AFP, which are to some degree tumour specific, HCC 
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can be targeted after systemic administration of the appropriate antibodies. By 
labelling the antibodies with iodine-131 or yttrium-90 a therapeutic dose of 
radiation can be delivered to the tumour specifically. The treatment was preceded 
by whole liver external beam irradiation, and radiosensitizers (doxorubicin and 5-
Fu) were added in the latter phase of the trial. The treatment was compared with 
systemic chemotherapy in a randomised trial which showed comparable response 
rates and survival duration. Those failing chemotherapy could still respond to 
131I-antiferritin treatment. Though the treatment is given systematically, its effect 
is mainly locoregional and the dose of131I-antifemtin is not sufficient to treat 
extrahepatic disease on its own. This is more effective than external radiotherapy 
alone. (P.J.Johnson, S. Ho and W.T.Leung, 1994) 
The above described was before the era of regional targeted treatment for 
HCC. In the early nineties, selective internal radiation has gained ground as the 
preferred treatment of this "difficult" tumour. 
2.7.2 Trans-catheter treatment of HCC 
Before the nineteen nineties there was no standard trans-catheter therapy for 
HCC patients. The trend was towards using intra-arterial regional targeted 
treatment since it was quite definite that malignant neoplasms growing in the liver 
had an exclusively arterial blood supply (Breedis and Young, 1954). It had been 
suggested that liver transplantation, if successful, might be the ideal treatment for 
cirrhosis-based HCC. However, this was costly and its contribution was very 
limited on a global scale (Okuda K. et al, 1985). 
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The types of trans-catheter treatment of HCC includes : 
2.7.2.1 Intra-arterial infusion chemotherapy 
Both primary and metastatic hepatic neoplasms derive their blood supply and 
nutrition from the arterial circuit. Thus the hepatic artery is an ideal route for 
selective delivery of therapeutic agents. The stimulus for using infusion therapy 
arises because of a poor median survival time in untreated patients and those 
receiving systemic chemotherapy. By infusing drugs directly into the tumour via 
the hepatic artery, local concentration of the anti-tumour agent is increased and 
systemic toxicity is decreased. Successful arterial infusion therapy depends on 
adequate perfusion of the entire liver and a safe delivery system. In early studies, 
a catheter was inserted percutaneously via the brachial or femoral artery but this 
approach suffered from the disadvantages that local and systemic sepsis was 
common after protracted infusions and that the patient was confined to bed and 
hospital. To overcome these problems, totally implantable systems have been 
developed. These systems are not without disadvantage. The implanted pumps 
are very expensive and require laparotomy for their insertion; those acting as a 
port are not easy to keep patent and in place over several months. The infusion of 
chemotherapy may result in chemical hepatitis or gastritis and ulceration. One 
major problem with this approach in HCC is the lack of effective drugs. 
2.7.2.2 Hepatic artery embolkation 
Hepatic artery embolization creates tumour devascularization, but the portal 
flow prevents infarction of liver parenchyma because of the single vascular supply 
from the hepatic artery to a neoplasm, in contrast to the dual vascular supply to 
the liver parenchyma. In the early eighties, indications for the use of hepatic 
artery embolization are failure of chemotherapy, either systemic or intra-arterial 
infusion, vascular anomalies requiring combined lobar embolization and lobar 
infusion, and lack of effective treatment 
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Mainly there are three types of embolization : peripheral embolization using 
Gelfoam, proximal embolization using coils, and combined peripheral and 
proximal embolization. The median survival duration was reported to be 11.5 
months from the time of embolization. 
Intrahepatic collaterals have been observed following both surgical ligation 
and coil embolization of the hepatic artery; some of these collaterals open 
instantaneously, others develop with time. To minimize collateral circulation and 
to create a more completely ischemic tumour, peripheral embolization of the 
hepatic artery is undertaken. Repeat embolization is necessary weeks to months 
later, because angiograms usually reveal inconsistent occlusion, probably due to 
resorption of Gelfoam and recanali2ation of hepatic arteries. Thus, proximal 
embolization of the hepatic artery following peripheral embolization with 
Gelfoam was the usual practice in the early eighties in North America. 
(V.P.Chuang and S.Wallace 1981) 
Now, in the nineties, simple arterial embolization on its own is less used in 
HCC, and this technique is usually used in combination with chemotherapy and 
other methods of loco-regional treatment. Its value in controlling severe pain has 
been recognised and it is still used for slow growing metastatic hormone-secreting 
hepatic tumours where it can lead to symptomatic control for several years. 
(P.J.Johnson, S. Ho and W.T.Leung, 1994) 
2.7.2.3 Transcatheter oily chemoembolization (TOCE) 
Lipiodol, when injected into the hepatic artery at the time of arteriography 
accumulates in hepatocellular carcinoma. Several groups firom the Far East have 
suggested that Lipiodol might be an ideal vehicle for targeting cytotoxic drugs 
because, after mixing with a therapeutic agent, it leads to an increased 
concentration of drug in the tumour. (P.J.Johnson, S. Ho and W.T.Leung, 1994) 
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Most commonly 60mg of doxorubicin is thoroughly mixed with 5ml of 
Lipiodol and injected into the tumor feeding arteries. This is followed by 
embolization with Gelfoam particles. It is important to confirm before the 
procedure that the portal vein is patent and, after the procedure, that the 
appropriate arteries have been embolized. The treatment is repeated on several 
occasions as the Gelfoam is reabsorbed within a few weeks and there is rapid 
recanalization. (P.J.Johnson, S. Ho and W.T.Leung 1994) 
Large series have been reported from Japan with survival figures at one year of 
around 50-75%, similar to those obtained by surgery. By the late eighties, the 
procedure was widely regarded as standard treatment. Later, studies showed that 
TOCE caused reduction in tumour size but there was little effect on long-term 
survival. Furthermore, most of the effect seen is due to the embolization, there 
being no proof that the Lipiodol targeting adds significantly. (P.J.Johnson, S. Ho 
andW.T.Leung, 1994) 
2.7.2.4 Selective internal radiation with Lipiodol-iodine-131 
HCC has an avidity for Lipiodol (Hoogewoud, 1993). By giving the 
radioactive Lipiodol-iodine-l31 intra-arterially, a therapeutic dose of irradiation 
can be delivered to the tumour. This treatment method has the theoretical 
advantage of preferential uptake of the radioactive iodine by the HCC and 
possibly decreases systemic toxicity. The thyroid is blocked by non-radioactive 
iodine before treatment to prevent uptake of the radioisotope. (P.J Johnson, S. 
Ho and W.T.Leung, 1994) 
The radioactive Lipiodol-iodine-131 is given slowly through an angiographic 
catheter which is placed in the tumor feeding hepatic artery. (P.J.Johnson, S. Ho 
and W.T.Leung, 1994) Since Lipiodol is radiopaque, the flow of the substance 
can be monitored under fluoroscopy. 
2-37 
Basic principle Previous classification 
Lipiodol-iodine-131 emits mainly gamma radiation with an energy of 364 keV. 
Due to this relatively low energy, its use is limited to tumours of less than 5 cm in 
diameter. The dose given ranges from 555 to 2220 MBq. (P.J.Johnson, S. Ho and 
W.T.Leung, 1994). The physical half-life of iodine-131 is 8.04 days. The 
biological half-life of the radioactive Lipiodol varies from patient to patient 
depending on blood flow, arteriovenous shunting and clearing by the 
reticuloendotheial cells. After treatment, the patient has to stay in hospital for 
approximately 10 to 14 days in order to allow the radiation, to decay to a safe level 
before discharging from the hospital. (P.J.Johnson, S. Ho and W.T.Leung, 1994) 
No major side effects were reported. (Bretagne and Raoul et al. 1988) 
Distribution of Lipiodol-iodine-131 can be detected by gamma camera and 
dosimetry data showed that HCC would receive on average eight times more 
irradiation than normal liver. (P.J.Johnson, S. Ho and W.T.Leung, 1994) 
However, from Hoogewoud, results seemed similar to those of other techniques 
such as chemoembolization. One of the advantages of internal radiation therapy 
is that it preserves hepatic vasculature and does not exclude the possibility of liver 
transplantation. . (Bretagne and Raoul et al., 1988) Despite the advantages, a 
limiting factor is the patient's psychological tolerance of isolation. 
2.7.2.5 Selective internal radiation with yttrium-90 microspheres 
The injection of radioactive microspheres through the hepatic artery is 
particularly appealing because it allows local administration of high radiation 
doses to the tumour without significant hepatic or systemic toxicity. (F.A. 
Shepherd & L.E. Rotstein, 1992) Yttrium-90 has several properties that make it a 
desirable agent for internal radiation therapy. It is a pure beta emitter with a mean 
energy of 0.93MeV (maximum, 2.27MeV). The average penetration in tissue is 
2.5mm. The physical half-life is 64.2 houts. Stable 89Y is incorporated easily into 
a glass matrix and can be activated to radioactive 90Y by means of neutron 
bombardment in a nuclear reactor. (F.A. Shepherd & L.E. Rotstein et al, 1992) 
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90Y microspheres are not biodegradable. Once infused into the liver, they will 
stay in the microvasculatxires of the tumour. In the early phase, the treatment 
procedure required laporotomy. The problems encountered included: 
• Myelosupression resulting from leaching of the radionuclide. 
• Pulmonary fibrosis resulting from arteriovenous shunting in the tumour 
circulation. 
• Gastritis due to the passage of radioactive microspheres into the 
gastroduodenal vessels. 
• Inability to calculate the radiation dose administered to the liver. 
The above problems were later solved by the followings : 
• The invention of the new 90Y glass microspheres. (M.J. Herba & F.F. 
Illecas et al, 1988) 
• Tc-MAA scan to predict the percentage lung shunting. 
• Tc-MAA scan to predict the relative T/N ratio. 
From October of 1992, laparotomy for 90Y microspheres therapy has no 
longer been performed since pre-treatment simulation using Tc-MAA scan to 
predict percentage of lung shunting and T/N ratio was verified. Now, 90Y-SIR 
therapy is performed during HAG with pre-treatment Tc-MAA scan. (Leung 
Wai-Tong, 1995) Although the technique for injecting 90Y microshperes is very 
much skill dependent and despite the large amount of activity handled during 
treatments, exposure of the personnel involved is minimal. (Hoogewoud, 1993) 
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2.7.2.5.1 Procedure of 90Y microspheres administration 
1. 90Y microspheres are made radiopaque by mixing with an equal 
volume of radiopaque contrast medium, Omnipaque 300. 
2. The suitable patient is subjected to HAG using the Seldinger 
technique. 
3. Arteriograms of the coeliac artery, superior mesenteric artery and 
hepatic artery are performed and carefully studied for the vascular 
map with special attention to any anomalies present. This is to 
accurately assess the tip of the catheter placement for the 90Y 
microspheres infusion. 
4. Catheter tip is placed in the feeding artery of the tumour or the proper 
hepatic artery distal to the branching off of the right gastric artery. 
5. Catheter position is the same as that for the previous pre-treatanent 
HAG with Tc-MAA scan. 
6. Catheter is then connected to a 4-way valve fixed on an injection 
bracket made with lcm thick perspex. 
7. A pre-determined dose of 90Y microspheres basing on the T/N ratio 
from pre-treatment Tc-MAA scan, is given into the angiographic 
catheter. 
8. The flow of the 90Y microspheres is monitored closely under 
fluoroscopy. 
9. The catheter is removed after the treatment and haemostasis secured. 
10. After the treatment, the patients are nursed in an isolation ward for the 
purpose of radiation protection and discharged home on day five post 
2-40 
Basic principle Trans-catheter treatment of HCC 
treatment when the radiation has decayed to a safe level. (Leung Wai-
Tong, 1995) 
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2.8 Prevalence of HCC in Hong Kong Chinese 
HCC is the most frequently occurring malignant tumour in the liver. It is 
currently the second commonest cancer death in Hong Kong. The incidence rate 
was 28.6 per 100,000 for the male and 7.7 per 100,000 for the female population 
in 1984. A total of 1,000 cases were registered in the year with a male to female 
ratio of 4 to 1. It consisted of 7.5% of all the cancer cases seen in Hong Kong. 
The incidence rate was rising steadily over the last 20 years from 16.9 in 1965 to 
28.6 per 100,000 in 1984. (Shiu et al., 1990) 
HCC is the seventh most common form of cancer in males and the ninth in 
females in Hong Kong. HCC accounts for 8.5% of all newly diagnosed cases of 
malignancy and 12.5% of all cancer deaths (Hong Kong Cancer Registry 1989, 
March 1993). In the year 1993, the number of deaths from malignant neoplasm 
of liver was 1168. The number of deaths has been increasing from 992 in 1984 to 
1168 in 1993 (annual report of the Department of Health of Hong Kong, 1st 
April 1993 - 31st March 1994). (Appendix V) 
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2.9 Management of HCC in Hong Kong 
In the Prince of Wales Hospital of the Chinese University of Hong Kong, the 
Joint Hepatoma Clinic takes care of the HCC patients. Previous study showed 
that, at presentation 83% of HCC patients had evidence of hepatomegaly 
suggesting that most of the tumours were very advanced and often beyond cure. 
The operability rate was 27% after ultrasonographic examination and this 
percentage dropped to 17% after hepatic arteriographic examination (W.T. Leung 
etal, 1994). The usual practice of the Joint Hepatoma Clinic is that all new patients 
are referred for ultrasound examination. After USG examination, the potentially 
operable patients are scheduled for HAG examination to further confirm 
operability. The operable patients are prepared for definitive surgery with 
abdominal CT scan and other pre-operative preparations. Those patients with 
bilobe disease, and/or extra-hepatic metastasis and/or portal vein invasion are 
considered inoperable. The inoperable patients are considered for palliative 
treatments. Palliative treatments include systemic chemotherapy, regional 
targeted treatment and general supportive care. (See Appendix VI for flow chart 
for HCC management) The vascular anatomy of each individual has great 
influence on the actual regional targeted treatment procedure. Thus, arterial 
variations are one of the important influencing factors upon the success of 
regional targeted treatment. 
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DEFINITIONS 
Considerable confusion often arises as regards the nomenclature of the arteries 
emanating from the coeliac axis. According to Michels, 1955, variational anatomy 
of the coeliac artery is so extensive that, in an investigation of 200 bodies, only 
about one half of the samples will conform to the standard anatomy textbook 
description. The main cause of aberrant morphology of the coeliac axis is the 
frequency and the diversity of origin and distribution of the hepatic arteries 
(Michels, 1955). It is suggested that the term coeliac axis be referred to the stem 
which typically gives rise to the left gastric, the splenic and the hepatic artery 
which then branches into the right, middle and left hepatic arteries. 
In this study, the researcher concentrates on the origins of the vessels and the 
hepatic arterial supply is considered the core. Basically, the suggested terminology 
is followed with the coeliac axis defined to be the stem which gives rise to the left 
gastric artery, and/or the splenic artery, and/or the hepatic arteries. Thus, the 
'normal' left gastric artery, the 'normal' splenic artery and the 'normal' common 
hepatic artery are all defined to be arising from the coeliac axis. 
Definitions 
3.1 Definition of normality 
With reference to the 'anatomy textbook normal' presentation of the coeliac 
axis and its branches, the definitions are: 
• Coeliac axis from aorta 
• Left gastric artery from coeliac axis 
• Splenic artery from coeliac axis 
• Common hepatic artery from coeliac axis 
• Proper hepatic artery from common hepatic artery 
• Right hepatic artery from proper hepatic artery 
• Left hepatic artery from proper hepatic artery 
• Middle hepatic artery from right hepatic artery or left hepatic artery 
• Gastroduodenal artery from common hepatic artery 
Right gastric artery from proper hepatic artery 
3.2 Accessory right or left hepatic artery 
With regards to the accessory hepatic arteries, the term 'accessory' only applies 
when there are more than one right or left hepatic arteries. The more distal artery 
or the one which is not from the coeliac axis is termed the accessory right or 
accessory left hepatic artery. Here the term accessory implies an 'extra' vessel. 
This 'extra' is to be interpreted only from the viewpoint of origin, for, functionally 
considered, all hepatic arteries are essential, as proved in the plastic casts made by 
Healey and Schroy in 1952 (Michels, 1955). 
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3.3 Middle hepatic artery 
The middle hepatic artery is not described or illustrated in anatomy texts. 
Michels said that the middle branch of the hepatic artery was known since the 
time of Haller (1756) and of Tiedemann (1822) and it should be included in all 
anatomy texts. Healey and Schroy designated the artery as the medial segment 
artery, for, they found that the middle hepatic (medial segment artery) supplied 
the medial segment of the left lobe of the liver. In Michels' study, about 45% of 
the middle hepatic arose from the right hepatic, about 45% from the left hepatic 
and 10% from other sources. Thus, whether the middle hepatic arises from the 
right or the left hepatic, it is considered a 'normal' presentation. 
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OBJECTIVES 
The aim of this study is to study the 'normal' and variant hepatic arterial supply 
and how the variant vascular pattern influence the tians-catheter 90Y-SIR 
treatment for HCC. The objectives are five folds : 
1. To establish the percentages of the variant origins of the coeliac axis and its 
branches in Hong Kong Chinese. 
2. To provide illustrative arteriograms of the observed anomalies. 
3. To find the influence of the anomalies upon trans-catheter 90Y-SIR therapy 
procedure. 
4. To confirm that the presence of anomalies is not a pre-disposing factor for 
HCC. 
5. To confirm that there is no gender difference in the anomalies. 
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MATERIALS, METHODS, AND SUBJECTS 
In this chapter, materials including equipment that was used in this research, 
subjects' preparation and selection criteria, sample si2e of the subjects and the 
method adopted for arteriographic analysis was discussed. 
5.1 MATERIALS 
5.1.1 Instrumentation 
In this study all arteriograms were performed by the consultant radiologist of 
the Prince of Wales Hospital, Dr. Michael Chan, using the Philips V3000 Digital 
Subtraction Angiographic (DSA) system ( Philips Medical Systems, 5680 DA 
BEST, The Netherlands). This system was equipped with the followings : 
• High-contrast fluoroscopy 
• Trace-subtraction fluoroscopy 
• Last Image Hold 
• Digital acquisition 
• Anatomically programmed radiography 
• Synchronized power injection of contrast medium with image acquisition 
• Real-time digital subtracted image acquistion 
• Polarity inversion 
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• Moving mask or new mask function 
• Landmarking function 
• Pixel shift function 
• Digital optical recording 
5.1.2 Contrast medium and its injection 
Non-ionic contrast medium Iopamiro 150 was used in the study. All contrast 
injections were performed using the automatic injector, Angiomat 6000 of the 
Liebel-Flarsheim Company (2111 East Galbraith Road, Cincinnati, Ohio 45215 
U.S.A.). The injection volume was 30ml per injection and the rate used was 8ml 
per second for the coeliac arteriogram and 6ml per second for the superior 
mesenteric arteriogram with optimization of contrast to reach region of interest. 
Injection pressure was automatically adjusted with the maximum set at 400psi. No 
patient suffered from any reactions due to the injection of the contrast medium. 
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5.2 METHODS 
5.2.1 Patient preparation 
All patients were prepared as follows: 
1. The patients were nil by mouth for 4 hours before the procedure. 
2. For each patient, an IV drip (on left side) was set up to keep the patient 
well hydrated. 
3. Suitable measures were taken in diabetic patients to prevent the 
development of hypoglycaemia or hyperglycaemia. 
4. Measures were taken to confirm that female patients of child bearing age 
were not pregnant on the day of the procedure. 
5. Both groin areas of each patient were prepared (shaved and cleaned) for 
arterial puncture. 
6. Evidence of coagulation defect was checked and corrected if necessary 
prior to the procedure. 
7. The patients (and/or patients' relatives) were fully informed as to the 
nature and risk of the procedure and signed consents were obtained from 
patients (and/or patients' relatives). 
8. In asthmatic patients and in patients with significant history of allergy, 
prophylactic steroid was given. 
9. Patient emptied his/her bladder before coming to the angiographic suite. 
5.2.2 Cathterization & Filming 
Cathterization was performed with the Seldinger technique. The tip of the 
angiographic catheter was positioned in the origin of the corresponding vessel of 
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interest and the appropriate arteriograms were obtained. The filming sequence 
used in each series was ‘2 frames/second for 3 seconds, 1 frame/second for 2 
seconds, then 1 frame at alternate second until the 23rd second'. No extra 
irradiation was incurred for hard copy documentation for this study. 
5.2.3 Method of arteriographic analysis 
5.2.3.1 Retrospective image retrieval 
This study included a series of cases from January of 1995 to December of 
1995. Arteriograms of subjects were retrieved from the system's hard disc or 
from archived optical disc files. Retrieved arteriographic images were all viewed 
on the viewing console of the V3000 System in digital subtracted positive format. 
The first image (i.e. the 0.5th second) was used as the mask and the second to 
fourth images were analysed. Standard magnification factor (x 4) were used. 
5.2.3.2 Arterial variant analysis 
After selecting the representative arteriograms, the arterial patterns were 
analysed with special attention to the arterial origins. 
The vessels studied were the coeliac, common hepatic, proper hepatic, right 
hepatic, middle hepatic, left hepatic, gastroduodenal, right gastric, left gastric, and 
splenic artery. The possible origins of the above arteries are listed below. 
1 Coeliac axis 
(i) Aorta (Ao) 
(ii) Superior Mesenteric Artery (SMA) 
(iii) Absent (Ab) 
2 Common hepatic artery 
(i) Coeliac axis (Coeliac) 
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(ii) Superior Mesenteric Artery (SMA) 
(iii) Aorta (Ao) 
3 Proper hepatic artery 
(i) Common hepatic artery (CH) 
(ii) Absent (Ab) 
4 Right hepatic artery 
(i) Proper hepatic artery (PH) 
(ii) Common hepatic artery (CH) 
(iii) Superior Mesenteric Artery (SMA) 
(iv) Accessory from SMA (ACC fr SMA) 
(v) Accessory from gastroduodenal artery (ACC fr GD) 
(vi) Absent (Ab) 
5 Middle hepatic artery 
(i) Right hepatic artery (RH) 
(ii) Left hepatic artery (LH) 
(iii) Right and Left hepatic (RH & LH) 
(iv) Absent (Ab) 
(v) Proper hepatic artery (PH) 
(vi) Common hepatic artery (CH) 
(vii) Gastroduodenal artery (GD) 
6 Left hepatic artery 
(i) Proper hepatic artery (PH) 
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(ii) Common hepatic artery (CH) 
(iii) Left gastric artery (LG) 
(iv) Accessory from left gastric artery (ACC fr LG) 
(v) Coeliac axis (Coeliac) 
(vi) Absent (Ab) 
7 Gastroduodenal artery 
(i) Common hepatic artery (CH) 
(ii) Right hepatic artery (RH) 
(iii) Left hepatic artery (LH) 
(iv) Coeliac axis (Coeliac) 
8 Right gastric artery 
(i) Proper hepatic artery (PH) 
(ii) Left hepatic artery (LH) 
(iii) Right hepatic artery (RH) 
(iv) Common hepatic artery (CH) 
(v) Gastroduodenal artery (GD) 
(vi) Absent (Ab) 
(vii) Middle hepatic artery (MH) 
(viii) Bifurcation of proper hepatic artery (BIF of PH) 
(ix) Bifurcation of common hepatic artery (BIF of CH) 
9 Left gastric artery 
(i) Coeliac axis (Coeliac) 
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(ii) Aorta (Ao) 
(iii) Bifurcation of coeliac axis (BIF of Coeliac) 
(iv) Absent (Ab) 
10 Splenic artery 
(i) Aorta (Ao) 
(ii) Superior Mesenteric Artery (SMA) 
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5.2.3.3 Data sheet 
In order to facilitate data recording for future analysis, the possible variants of 
the ten arteries studied are charted up in the sample data sheet shown in figure 
5.01. 
The vertical row represents the ten arteries studied and their respective 
possible origins and the hori2ontal row denotes the individual subjects (in 
assigned numbers). Any identification of one possible origin of the vessels studied 
would be entered as ‘one and after counting all 276 subjects, the sum of each 
category of possible origin would be calculated. From the numbers, further 
calculation of the percentages of each listed possible origin of the vessels studied 
would be made. 
5.2.3.4 Radiographic images and trace drawings 
All illustrative arteriograms shown in this thesis were scanned from the original 
digital subtracted arteriograms using the HP 4P Desk Scanner. All trace diagrams 
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5.3 SUBJECTS 
5.3.1 Basic inclusion criteria 
All subjects included were clinically suspected to have abdominal masses or 
gastro-intestinal problems. Patients were collected at random with no sex 
predilection. Subjects who had abdominal operations were excluded since any-
abdominal operation might alter the abdominal vascular pattern. 
5.3.2 Confirmation criteria 
The subjects included were either suffering from HCC, gastro-intestinal 
bleeding or other abdominal tumours. Confirming diagnosis were based on the 
following criteria. 
5.3.2.1 Hepatocellular carcinoma (HCC) (n= 166) 
• Positive hepatitis B surface antigen (+ HBsAg) (n=166) 
• Raised alpha feto-protein level (equal or greater than 500 ng/ml) 
(n=166) 
• Presence of solitary or query multiple focal hepatic lesion on USG 
(n=166) 
• Presence of solitary or query multiple focal hepatic lesion on CT scan 
with or without lipiodol (n=166) 
• Presence of solitary or query multiple focal hepatic lesion on 
arteriography with or without lipiodol (n 16(S) 
• Histo-pathological tissue confirmation (n=41) 
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5.3.2.2 Gastrointestinal problems (n=105) 
• Clinical suspicion of internal bleeding particularly the gastrointestinal 
origin (n=105) 
• Positive 99m-Technitium labelled Red Blood Cell scan (n=5) 
• Normal alpha feto-protein level (equal or smaller than 10 ng/ml 
(n=100) 
• Absence of solitary or multiple focal hepatic lesion on USG (n=105) 
• Absence of solitary or multiple focal hepatic lesion on arteriography 
without lipiodol (n=105) 
• Presence of leakage of contrast on arteriography (n=4) 
5.3.2.3 The remaining five subjects : 
Two subjects had metastases with multiple hepatic lesions on USG scan and 
known primary malignancies. 
Two subjects had cavernous haemangioma with characteristic arteriographic 
appearance and normal alpha feto-protein level (equal or smaller than 10 ng/ml). 
One subject had a retro-peritoneal mass. 
5.3.3 Final number of subjects recruited 
From January of 1995 to Feburary of 1996 276 subjects were recruited, and 
197 were males and 79 were females. Age ranged from 17 to 92 with a median of 
54 13 years. 166 subjects were having HCC and 110 subjects with no HCC. 
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RESULTS 
From January of 1995 to Feburary of 1996, the upper abdominal angiograms 
of 276 subjects were analysed. Of the 276 subjects (figure 6.01 & figure 6.02)), 
197 were males and 79 were females; and 166 subjects were diagnosed to have 
HCC with the other 110 subjects having gastro-intestinal problems or other upper 
abdominal lesions. Age ranged from 17 to 92 with a median of 54±13 years. 
When tested with the Kolmogorov-Smirnov Goodness of Fit Test, the age 
distribution frequency was a normal distribution (figure 6.03) with a 2-tailed p 
value of 0.06 which is greater than 0.05. 
In this chapter, the percentages of the variants observed for each vessel 
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6.1 Coeliac axis 
The classical presentation of the coeliac axis is from the aorta (figure 6.04a). 
The observed percentages of the origin of the coeliac axis is listed in table 6.01 
and figure 6.06. In this study, 98.6% of the subjects have the coeliac axis 
originating from the aorta. Other possible origin of the coeliac axis is the superior 
mesenteric artery or the coeliac axis is completely absent. Figure 6.07a and figure 
6.07b show an example of the coeliac axis arising from the superior mesenteric 
artery. The subject with the absent coeliac actually has the common hepatic 
artery stemming directly from the aorta (figure 6.08a), the splenic artery 
originating firom another site of the aorta separately (figure 6.08b) and the left 
gastric artery arising from the splenic artery. 
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Table 6.01 Origin of the coeliac axis 
Vessel origin Number observed Percentage IUustration 
A o r t a
 272 98.6% figure 6.04 
S u P e r i o r mesenteric artery 3 1.1% figure 6.07a 6.07b 
A b s e n t
 1 0.4% figure 6.08a, 6.08b 
Figure 6.06 Origin of the coeliac axis 
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6.2 Common hepatic artery 
The classical presentation of the common hepatic artery is from the coeliac 
axis (figures 6.04a & 6.05a & 6.05b). Table 6.02 and figure 6.09 list the observed 
percentages of the origin of the common hepatic artery. There is a 97.8% of the 
subjects having the common hepatic artery originating from the coeliac axis. 
Table 6.02 Origin of the common hepatic artery 
Vessel origin Number observed Percentage Illustration 
Coeliac axis 270 97.8% figure 6.05a, 6 .05b~ 
Superior mesenteric artery 4 1.4% figure 6.10a, 6.10b 
Aorta 2 0.7% figure 6.08a 
Figure 6.09 Origin of the common hepatic artery 
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6.3 Proper hepatic artery 
The proper hepatic artery is a continuation of the common hepatic artery 
classically (figure 6.04 & figure 6.05). The other common variant is an absent 
proper hepatic artery. In the study, 80.4% of the subjects have the classical 
presentation of the proper hepatic artery and 19.6% do not have a proper hepatic 
artery (table 6.03 & figure 6.11). In the illustration shown in figure 6.10a, the 
subject presents with two variants, one is an absent proper hepatic and the other 
is a common hepatic arising from the superior mesenteric artery. 
Table 6.03 Omin of the proper hepatic artery 
Vessel origin Number observed Percentage Illustration 
Common hepatic artery 222 80.4% figure 6.04, 6.05 
A b s e n t 54 19.6% figure 6.10a, 6.10b 
Figure 6.11 Origin of the proper hepatic artery 
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6.4 Right hepatic artery 
The text book presentation of the right hepatic artery is from the proper 
hepatic artery (figure 6.04 & figure 6.05). In this study, 80.4% of the subjects 
have this text book presentation. The other observed variants of the origin of the 
right hepatic artery are from the common hepatic artery or the superior 
mesenteric artery. An accessory right hepatic can also arise from the superior 
mesenteric artery (figure 6.14ai & 6.1 are arteriograms of the same subject 
demonstrating the presence of an accessory right hepatic originating from the 
superior mesenteric artery in addition to a right hepatic artery originating from the 
proper hepatic artery), or from the gastroduodenal artery, the coeliac axis, or the 
propel hepatic artery. The observed frequency of these variants are listed in table 
6.04 and figure 6.12. 
Table 6.04 Orinn of the right hepatic artery 
Vessel origin Number observed Percentage Illustration 
Proper hepatic artery 222 80.4% figure 6.04 6.05 
Common hepatic artery 39 14.1% figure 6.10a, 6.10b 
Superior mesenteric artery 13 4.7% figure 6.13a, 6.13b 
Accessory from SMA 3 1.1% figure 6.14a, 6.14b 
Accessory from GD 2 0.7% figure 6.15a, 6.15b 
Coeliac axis 2 0.7% figure 6.16a, 6.16b 
Accessory from PH 1 0.4% figure 6.17a, 6.17b 
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Fimre 6.14b Schematic diagram showing 'ACC RH fr SMA 
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6.5 Middle hepatic artery 
The middle hepatic artery arises either from the right hepatic artery or the left 
hepatic artery classically. In this study 44.2% of the subjects have the middle 
hepatic artery arising from the right hepatic artery (figure 6.04). 32.6% subjects 
have the middle hepatic artery originating from the left hepatic artery and 14.9% 
of the subjects have the middle hepatic artery arising from both the right and left 
hepatic arteries either in the form of two discrete arteries or a plexus of arteries. 
Other valiants of the origin of the middle hepatic artery include the proper 
hepatic artery, common hepatic artery, gastroduodenal artery accessory left 
hepatic artery. Occasionally the middle hepatic artery is absent These occurrence 
are tabulated in table 6.05 and figure 6.18 
Table 6.05 Origin of the middle hepatic artery 
Vessel origin Number observed Percentage Illustration 
Right hepatic artery 123 44.6% figure 6.19a, 6.19b 
Left hepatic artery 90 32.6% figure 6.20a, 6.20b 
R H & L H 41 14.9% figure 6.21a, 6.21b 
Absent 14 5.1% 
Proper hepatic artery 5 1.8% figure 6.22a, 6.22b 
Common hepatic artery 2 0.7% figure 6.23 
Gastroduodenal artery 1 0.4% figure 6.24 
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6.6 Left hepatic artery 
The left hepatic artery arises from the proper hepatic artery classically (figure 
6.04 & figure 6.05). In this study, 77.5% of the subjects have this classical 
presentation of the left hepatic artery. Other observed variants of the origin of 
the left hepatic artery are the common hepatic artery, left gastric artery, and 
coeliac axis. Occasionally there is an accessory LH from the left gastric artery and 
sometimes the left hepatic artery is absent. The different percentages are 
tabulated in table 6.06 and figure 6.26. 
Table 6.06 Origin of the left hepatic artery 
Vessel origin Number observed Percentage Illustration 
Proper hepatic artery 214 77.5% figure 6.04, 6.05 
Common hepatic artery 40 14.5% figure 6.27 
Left gastric artery 20 7.2% figure 6.28 
Accessory from LG 11 4.0% figure 6.29 
Coeliac axis 1 0.4% figure 6.16a, 6.16b 
Absent 1 0.4% figure 6.15a 
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6.7 Gastroduodenal artery 
In this study, 93.1% of the subjects have the gastroduodenal artery originating 
from the common hepatic artery which is the classical presentation of this vessel 
(illustrated by figure 6.04 & figure 6.05). Other variant origins of this vessel are 
the right hepatic artery, left hepatic artery, and the coeliac axis. These are listed in 
table 6.07 and figure 6.31. 
Table 6.07 Origin of the gastroduodenal artery 
Vessel origin Number observed Percentage Illustration 
Common hepatic artery 257 93.1% figure 6.04, 6.05 
Right hepatic artery 14 5.1% figure 6.32 
Left hepatic artery 4 1.4% figure 6.33a, 6.33b 
Coelaic axis 1 0.4% figure 6.16a, 6.16b 
Figure 6.31 Origin of the gastroduodenal artery 
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6.8 Right gastric artery 
From anatomy text books, the right gastric artery originates from the proper 
hepatic artery (figure 6.04 & figure 6.05). Although this artery is usually small, it 
has many variants and all these variants warrant special attention when 
considering Selective Internal Radiation (SIR) treatment for hepatocellular 
carcinoma. Table 6.08 and figure 6.34 list the origins and the respective 
percentages observed. 
Table 6.08 Origin of the right gastric artery 
Vessel origin Number observed Percentage Illustration 
Proper hepatic artery 116 42.0% figure 6.04, 6.05 
Left hepatic artery 98 35.5% figure 6.35a, 6.35b 
Right hepatic artery 28 10.1% figure 6.36a, 6.36b 
Common hepatic artery 12 4.3% figure 6.37a, 6.37b 
Gastroduodenal artery 10 3.6% figure 6.38a, 6.38b 
Absent 6 2.2% 
Middle hepatic artery 3 1.1% figure 6.23 
Bifurcation of PH 2 0.7% figure 6.39a, 6.39b 
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6.9 Left gastric artery 
The left gastric artery arises from the coeliac axis as quoted from anatomy text 
book (figure 6.04a) and this norm is observed in 94.2% of the subjects in this 
study (figure 6.05a & 6.05b). The other variant anatomy of the left gastric artery 
is tabulated in table 6.09 and figure 6.41. Figure 6.42a shows a lateral view of the 
left gastric artery arising from the aorta. This radiograph is copied from 
Saadoon's Atlas of Normal and Variant angiographic anatomy, since no extra 
angiograms were obtained specially for this study and the six observed left gastric 
artery originating from aorta were observed from test fluoroscopy during 
catheterization of the coeliac axis. 
Table 6.09 Origin of the left mstric artery 
Vessel origin Number observed Percentage Illustration 
Coeliac 261 94.6% figure 6.05a 6.05b 
Aorta 6 2.2% figure 6.42a 6.42b 
Bifurcation of Coelaic 5 1.8% figure 6.43 
Absent 4 1.4% 
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6.10 Splenic artery 
The classical presentation of the origin of the splenic artery is shown here in 
figures 6.05a and 6.05b. The percentage obtained of this classical pattern in this 
study is 99.3%. Other variant origins of the splenic artery include the aorta and 
the superior mesenteric artery (table 6.10 & figure 6.45). 
. 
Table 6.10 Origin of the spenic artery 
. ‘ 
Vessel origin Number observed Percentage Illustration 
Coelaic axis 274 99.3% figure 6.05a, 6.05b 
Aorta 1 0.4% figure 6.08b 
Superior mesenteric artery 1 0.4% figure 6.46a, 6.46b 
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6.11 Summary of results 
Figure 6.47 is a summary chart of the percentages of the origins of the vessels 
being studied. The highest occurrence of each individual vessel is that of the 
classical pattern. (Refer to section 3.1 for the classical pattern) Although each 
individual vessel has the highest occurrence as that of the classical pattern, when 
considering all the ten vessels, only 28% of the subjects have no variant as that 
shown in figure 6.04a. In another words, 72% of the subjects have at least one 
variant (figure 6.48). When considering the hepatic arterial blood supply only, the 
varied character of the arterial blood supply to the liver are due primarily to the 
varied origins of the three major liver arteries, viz., the right, the left and the 
middle hepatics (Michels,1955). There are 55.4% of the subjects possessing all 
the three liver arteries with the classical pattern (Figure 6.49). Michels obtained a 
55% in his study. These 2 percentages are tested for significance of difference 
using the Chi-square test. The p-value obtained is 0.47 which is greater than 0.05. 
This result do not differ significantly from that obtained by Michels. 
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For surgeons, the best way to avoid injury to blood vessels is to know them, 
and to know how, when and where to ligate them properly (Michels,1955). 
Whereas, for the radiological interventionalist, the only way to achieve precise 
endovascular treatment is to know the vascular pathways and their final capillary 
beds, and to know how, where and how much of the therapeutic drug to deliver 
properly. The objective of 90Y-SIR is to deliver the maximum radiation dose to 
the tumour avoiding any dose to significantly sensitive 'innocent bystander' 
arteries. In the situation under consideration, these are the arteries supplying the 
stomach and the duodenum. The endovascular treatment of Selective Internal 
Radiation using 90Y for hepatocellular carcinoma is described in chapter two, 
section 2.7. The Svhere' for both the surgeon and the interventionist closely 
associates with the theme of this study, anomalies of vessels. In this study, the 
anomalies of the coeliac axis and its branches are studied. The previous large 
scale study of the arterial variants of the upper abdomen was done in 1955 by 
Michels. Whence, 200 cadavers were dissected and analysed. In this study, 276 
subjects' arteriograms of the coeliac axis and superior mesenteric artery were 
analysed. The percentages of the variants of the coeliac axis and its branches in 
Hong Kong Chinese were established and presented in the chapter six. 
Discussion Introduction 
In the following section, endovascular treatment procedure is classified into 
two main types with four subtypes. The method of approach in the classical 
pattern of the coeliac axis is described. Each of the ten vessels studied are 
discussed in turn with regard to the following aspects: 
• Comparison with Michels' study. 
• The influence of the anomalies upon intraarterial 90Y treatment for HCC. 
Finally there are three sections on : 
1 • comparison of the results of this study with that quoted by Michels, 
2. comparison of the findings in the group of subjects with hepatocellular 
carcinoma with that in the group without hepatocellular carcinoma, 
3. and, comparison of the results obtained from the male subjects and that from 
the female subjects. 
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7.2 Selective Internal RadiationTherapy 
Results from Lau & Ho s (1997) study show that intraarterial 90Y microspheres 
given through an angiographic route is a feasible treatment for non-resectable 
HCC. During the angiographic procedure for infusion of 90Y microspheres, the 
two major objectives are, first, to deliver the 90Y microspheres to the HCC and, 
second, to avoid radiation induced gastritis due to this treatment. 
The first objective is achieved by delivering the 90Y microspheres 
superselectively to the arterial supply of the tumour. 
The measures taken to avoid radiation induced gastritis include the followings : 
1. Superselective catheterization of the hepatic artery by-passing the 
gastroduodenal artery and the right gastric artery for the 90Y microspheres 
infusion. 
2. The 90Y microspheres suspension is rendered visible fluoroscopically by 
adding to it a radiopaque contrast medium, Omnipaque 300. 
3. Infusion of the 90Y microspheres is performed under fluoroscopic 
monitoring, thus preventing reflux of the radioactivity into the 
gastroduodenal artery. 
With the two mentioned objectives in mind, basically, the endovascular 
treatment procedure can be classified into two types as follows : 
• Type I 
Superselective cathetemation of the hepatic arteries. 
• Type II 
Superselective catheterization of the hepatic arteries preceded by embolization 
of some relevant arteries either to protect the stomach or for flow re-
distribution. 
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Each type can be further subdivided into the following subtypes: 
• Type I-a 
Superselective catheterization of one hepatic artery and infusing it with the 
90Y microspheres. 
• Type I-b 
Superselective catheterization of more than one hepatic arteries and infusing 
them with 90Y microspheres in turn. 
• Type Il-a 
Superselective catheterization of one or more hepatic arteries and infusing 
them in turn with 90Y microspheres preceded by embolization of one or 
more gastric arteries to prevent radioactive microspheres going to the 
stomach and duodenum. Embolization of the gastric arteries causes no harm 
to the gastrointestinal tract as the other gastric vessels will hypertrophy to 
compensate for the embolked artery/arteries. 
• Type Il-b 
Superselective catheterization of one or more hepatic arteries and infusing 
them in turn with 90Y microspheres preceded by embolkation of a hepatic 
artery, which may or may not be a variant, for flow re-distribution. The 
embolization site is to be at the proximal end of the artery and collaterals will 
open virtually instantaneously. This collateral circulation will carry more 90Y 
microspheres to the tumour. 
No matter which type of endovascular treatment procedure is employed, the 
guiding catheter should be placed at the relatively larger vessel such as the coeliac 
axis or the common hepatic artery. A coaxial catheter threaded inside the guiding 
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catheter and advanced to the desired site is used for infusion of the 90Y 
microspheres or for delivering the embolization agent. 
Figure 7.01 shows a hypothetical HCC involving both the right and the left 
lobes and the appropriate catheter placement is shown. The type I-a 
endovascular treatment procedure is applied. The tip of the guiding catheter is 
placed at the proximal end of the coeliac axis and the tip of the coaxial catheter is 
placed at the proper hepatic artery by-passing the right gastric artery. In this way, 
the 90Y microspheres can be delivered to the tumour and radiation induced 
gastritis can be avoided. 
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Figurv 7.01 Catheterplacement for ^ Y delivery for the classicalpattern of the coeliac axis 
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7.3 The coeliac axis 
In this study, no direct comparison with Michels' can be made since the 
classification method is different. When considering catheter placement for SIR 
treatment, for the majority of the subjects who have the coeliac axis originating 
from the aorta, the guiding catheter should be advanced through the abdominal 
aorta into the proximal part of coeliac axis, as shown in figure 7.01. If the coeliac 
axis arises from superior mesenteric artery, the guiding catheter should be 
advance through the abdominal aorta into the superior mesenteric artery (figure 
7.02 & 6.07a). For the absent coeliac, the origin of the common hepatic artery 
has to be ascertained. As in the case shown in figure 6.08a, the common hepatic 
artery arises directly from the aorta, the guiding catheter should be advanced 
through the abdominal aorta and into the proximal end of the common hepatic 
artery (figure 7.03). The exact position of the coaxial catheter tip placement 
depends on the liver arterial supply, origin of the right gastric and gastroduodenal 
artery, and any other variant arterial supply of the liver and the stomach. These 
are discussed in the coming sections when appropriate. 
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7.4 The common hepatic & proper hepatic artery 
The proper hepatic artery is an important artery since in most cases the 
infusion site of the 90Y microspheres is at the proper hepatic artery instead of at 
the common hepatic artery to avoid radiation induced gastritis. In Michels' work, 
the whole length of the hepatic vessel arising from the coeliac before branching 
into the right, left and middle hepatic arteries was termed the hepatic artery. 
Thus, during comparison, the hepatic artery referred in Michels' study could be 
analogous to the common hepatic artery in this study. Comparison of the 
percentages of the variant origins of the common hepatic artery in this study and 
Michels' is tabulated in table 7.01. 
Table 7.01 Comparison of the % of the variant origins of the common hepatic artery 
Percentage 
Vessel origin In this study In Michels work p-value 
Superior mesenteric artery 1.4% 2.5% 0.31 
Aorta 0.7% 1.5% 0.35 
Left gastric 0% 0.5% 0.42 
The observed percentages from the two studies are compared using the Chi-
square test. Each of the p-values obtained is greater than 0.05, which means that 
the results of the two studies do not differ significantly in this aspect. 
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One significantly different result was obtained from Pedro Belou, of Buenos 
Aires (1915), in which there was a 6% of the bodies having the common hepatic 
artery arising from the superior mesenteric artery. (Michels, 1955) While in this 
study of the Hong Kong Chinese, a 1.4% is observed. This discrepancy may be 
due to racial difference or different research methodology or other reasons, but 
finding the reasoning behind is beyond the scope of this study. 
When considering the catheter placement for SIR treatment for HCC, for the 
majority who have the common hepatic artery stemming from the coeliac axis, 
the coaxial catheter should be advanced out from the guiding catheter into the 
common hepatic artery (figure 7.01). For the variant of the common hepatic 
from the superior mesenteric, the guiding catheter has to be advanced through 
the aorta into the superior mesenteric artery (figure 7.04). The coaxial catheter is 
advanced into the common hepatic and then into the proper hepatic artery. 
Figure 7.05a shows one variant in which the hepatic artery stems from the left 
gastric artery. This variant was reported from Michels' work but not observed in 
this study. For this vascular pattern, the endovascular procedure for SIR 
treatment has to be modified. In Michels' presented case, there was one more 
variant which warranted attention if the 90Y-SIR treatment were to be carried out. 
The right gastric artery arising from the right hepatic artery. To avoid radiation 
induced gastritis, the tight gastric artery has to be embolized first. Then infusion 
of the 90Y microspheres could be proceeded on with the infusion site at the 
proper hepatic artery. According to the classification described in section 7.2 this 
is the 'Type II-a endovascular treatment procedure. The procedures of 
embolizing the right gastric artery and positioning of the coaxial catheter tip at the 
appropriate infusion site in the hepatic artery is easier said than done. Both 
procedures involve manipulating the coaxial catheter a long distance. In the 
procedure for embolizing the right gastric artery, manipulation of the coaxial 
catheter into the right hepatic artery and into the right gastric artery to deliver the 
embolization coil requires expert skill. The theoretical placement of the catheters 
for 90Y-SIR treatment is shown in figure 7.05b. 
7-11 
Discussion Common & Proper hepatic 






/ / / 
/ / 
« Guiding catheter 
/ 
From figure 6.10a 
\ t 
' f f 
^ ) 
R f , 
^ W m ' ^ i W s v S 
7-12 
Discussion Common & Proper hepatic 
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7.5 The right hepatic artery 
In this study, the normal origin of the right hepatic artery is defined to be 
arising from the proper hepatic artery. All other sites of origin of the tight hepatic 
artery or the existence of an accessory right hepatic artery are referred to as 
variants. In this study, 54 (19.6%) variant right hepatic arteries were encountered, 
while there were 52 (26%) variant right hepatic arteries encountered in Michels' 
study. Using the Chi-square test to compare the two, the p-value obtained is 0.12 
which is greater than 0.05. This means that the two percentages do not differ 
significantly. Despite these apparently similar results, the percentages of the 
different variants do vary. Table 7.02 lists the percentages and the p-values of the 
different variants. Upon statistical testing, the percentages of a right hepatic artery 
arising from the superior mesenteric artery, a right hepatic artery arising from the 
aorta and an accessory right hepatic artery stemming from the superior mesenteric 
artery obtained in this study differ significantly from that reported in Michels' 
work. The three percentages in Michels' work are significantly greater than that in 
this study. These discrepancies may be due to racial difference but this topic is 
beyond the scope of this study. 
Table 7.02 Comparison of the % of the variant origins of the rioht hepatic artery 
Percentage 
Vessel origin In this study In Michels' work p-value 
Superior mesenteric artery 4 J % 12.5% 0.003 <0.05 
Coeliac 0.7% 3.0% 0.062 
Aorta 0% 2.0% 0.031 <0.05 
Left gastric 0% 0.5% 0.420 
Accessory RH from SMA 1.1% 4.5% 0.041 <0.05 
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During the endovascular procedure for 90Y-SIR treatment, for the 'normal' 
right hepatic artery arising from the proper hepatic, the catheter placement is as 
shown in figure 7.01. Modifications are needed in order that the 90Y 
microspheres could be delivered to the entire arterial supply of the HCC when the 
right hepatic artery is displaced out of the main hepatic trunk or when an 
accessory right hepatic artery is present. 
Figure 7.06 shows one example of a right hepatic artery originating from the 
superior mesenteric artery. The theoretical catheter placement is shown and the 
90Y microspheres is to be infused at the proximal end of the right hepatic artery. 
For this subject, at least one infusion of the 90Y microspheres has to be given. The 
endovascular treatment procedure may be of 'Type I-a or 'Type II depending on 
the vascular anatomy of the other hepatic arteries and the related gastric vessels. 
In the presence of an accessory right hepatic artery, theoretically, this 
accessory right hepatic has to be infused with 90Y microspheres in addition to 
infusion at the main hepatic trunk. Figure 7.07 shows an example of an accessory 
right hepatic artery from the gastroduodenal. For this vascular pattern two 
infusions of the 90Y microspheres are required, that is the 'Type I-b' endovascular 
treatment procedure can be applied. The catheter placement for infusing at the 
accessory right hepatic is demonstrated in the 'figure 7.07' and the other infusion 
site at the proper hepatic artery is illustrated in the same figure. 
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Figure 7.06 Catheterplacement for 90Y delivery for "RHjr SMA 
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7.6 The middle hepatic artery 
According to anatomy textbook, the normal origin of the middle hepatic artery 
is the right hepatic or the left hepatic artery (figure 6.19a & 6.20a). In this study, 
44.6% of the middle hepatic arteries arise from the right hepatic and 32.6% from 
the left hepatic artery. Corresponding figures quoted from Michels' work were 
both 45%. Upon statistical testing using Chi-square test, the p-values obtained 
are 0.94 and 0.59 respectively. This implies that the percentages obtained about 
the middle hepatic from the two studies do not differ significantly. In Michels' 
work, the remaining 6% of the middle hepatic arose from the coeliac, hepatic, 
gastroduodenal, or right gastric artery. Figure 7.08 is from Michels' text and 
according to his classification the origin of this middle hepatic is the right gastric 
artery. On the other hand, according to classification of this study, the middle 
hepatic artery is said to give rise to the right gastric artery instead of the other way 
round. Thus, direct comparison in this context of different classification cannot 
lead to any meaningful conclusion although the statistical value for comparison 
can be obtained. 
The middle hepatic artery supplies the medial segment of the left lobe. Thus, 
the middle hepatic artery cannot be neglected when considering 90Y-SIR 
treatment. When the middle hepatic artery arises from either the right or the left 
hepatic artery, any modification needed during the endovascular treatment 
procedure is according to the presentation of the right or the left hepatic artery 
respectively. The right hepatic artery is discussed in the previous section and the 
left hepatic is discussed in the next section. When there exist more than one 
middle hepatic arteries arising from the right and the left hepatic artery 
simultaneously, neither one can be neglected. In the vascular presentation shown 
in figure 7.09 the 'Type I-a endovascular treatment procedure can be applied 
with one infusion of the 90Y microspheres at the proper hepatic artery as 
illustrated in the sketch. 
Other variant origins of the middle hepatic include the proper hepatic, the 
common hepatic and the gastroduodenal artery. 
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Figure 7.10 shows a middle hepatic artery arising from the proper hepatic. It is 
necessary to infuse the 90Y microspheres at the proper hepatic artery prior to the 
branching off of the middle hepatic artery. For this subject, the left hepatic artery 
arises from the left gastric artery. If the tumour does not involve the left lobe of 
liver, the ‘Type I-a' endovascular treatment procedure can be applied. 
When considering the vascular presentation shown in figure 7.11 with the 
middle hepatic artery arising from the common hepatic artery, the 'Type II 
endovascular treatment procedure is applied. Before the infusion of the 90Y 
microspheres, the middle hepatic artery is embolized. Collaterals developed will 
carry the 90Y microspheres to the medial segment of the left lobe and at the same 
time the 90Y microspheres are prevented from going into the right gastric artery 
since this right gastric artery arises from the middle hepatic. This procedure is a 
combination of the 'Type II-a and 'Type II-b endovascular treatment procedure. 
Another example of the combination of the 'Type II-a and 'Type II-b 
endovascular treatment procedure is shown in figure 7.12. Here, the middle 
hepatic artery arises from the gastroduodenal. Before infusion of the 90Y 
microspheres at the right hepatic artery, the gastroduodenal artery is embolized at 
the proximal end. The collaterals developed will infuse the medial segment of the 
left lobe of the liver and the gastroduodenal artery is protected. If the tumour 
also involves the left lobe, the tiny left hepatic has to be embolized prior to 
treatment. 
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Figure 7.08 The middle hepatic stemming from the right gastric artery 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive 
Atlas by N^A. Michels) 
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Figure 7.11 Catheterplacement for 90Y delivery for MHJr CH 
Trace drawing 
r ) 
m h v ^ ^ / r 
• / 
f i R G
 j 
-" '_ Guiding catheter 
Coaxial catheter 
0
 Infusion site 
* Embolization agent 
From figure 6.23a 
j M 
‘ - . . , Mum H J^ 
^ M R G 
J 
7-23 
Discussion Middle hepatic 
Figure 7.12 Catheter placement for 90Y delivery for (MHfr GD 
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7.7 The left hepatic artery 
As previously stated, the normal origin of the left hepatic is the proper hepatic. 
In this study, 77.5% of the subjects have this normal origin. Other variant origins 
include common hepatic artery, left gastric artery, and coeliac axis. Sometimes 
the left hepatic artery is absent or an accessory left hepatic artery may arise from 
the left gastric artery. When comparing with Michels' work, only two pairs of 
percentages are available and they are tested using the Chi-square statistical test. 
The p-values are listed in the following table (Table 7.03). 
Table 7.03 Comparison of the % of the variant origins of the left hepatic artery 
Percentage 
Vessel origin In this study In Michels work p-value 
Left gastric artery 7.2% 11.5% 0.15 
Accessory LH from left gastric 4.0% 11.5% 0.003 <0.05 
One significant difference observed is that the percentage of an accessory left 
hepatic artery arising from the left gastric in Michels' work is much higher than 
that in this study. 
In 1.5% of the subjects in Michels' study, the left hepatic arose from the aorta. 
None was observed in this study. In this study, no extra radiation exposure was 
imparted to the individuals, each individual had a coeliac arteriogram and a 
superior mesenteric arteriogram routinely and the arteriograms were analysed 
retrospectively. There was one subject with absent left hepatic artery. This meant 
that the individual did not have a left hepatic artery from the coeliac axis or from 
the superior mesenteric artery. The left hepatic artery might take origin from the 
aorta which was missed in this particular case. Thus, direct comparison of the 
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results from these two studies did not lead to meaningful implication when the 
research methods employed were different. 
Variant left hepatic can be grouped into two types, the left hepatic being 
displaced from the coeliac axis and the presence of an accessory left hepatic. 
Generally speaking, the ‘Type I-b or the 'Type II endovascular treatment 
procedure is applicable depending on the origin of the left hepatic artery or the 
accessory left hepatic artery and the presentation of the other hepatic arteries. 
Figure 7.13 and figure 7.14 show a left hepatic artery from the common 
hepatic artery and from the left gastric artery respectively. Unless the left lobe of 
the liver is spared from the tumour, the left hepatic artery has to be infused with 
90Y microspheres at its proximal end in addition to infusion for the other hepatic 
arteries. 
The existence of an accessory left hepatic amounts to 4%. As a basic 
principle, infusion is preferred to embolization since active treatment is preferred 
to passive treatment. That is 'Type I-b treatment procedure is preferred to 'Type 
Il-b' treatment procedure. The ground rule is to infuse the accessory left hepatic 
separately during the endovascular treatment procedure unless the accessory left 
hepatic is small in calibre. Figure 7.15 shows an accessory left hepatic arising 
from left gastric artery. The calibre of the accessory left hepatic is relatively 
smaller than that of the left gastric. Infusion of radioactive drug into the small 
accessory left hepatic might lead to reflux into the left gastric which in turn will 
cause radiation gastritis. Thus, it is wise to embolize the accessory left hepatic 
allowing the collaterals to infuse the territory supplied by the accessory left, and to 
infuse the 90Y microspheres at the proper hepatic artery. 
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Figure 7.15 Catheterplacement for 90Y delivery for 'ACC LH fr LG 
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7.8 The Gastroduodenal artery 
The anatomy text book normal origin of the gastroduodenal artery is the 
common hepatic artery. In this study, 93.1% of the individuals presented with 
this origin. Other variant origins include right hepatic, left hepatic and coeliac 
axis. The following table (Table 7.04) lists the p-values and the different 
percentages about the gastroduodenal artery obtained from this study and 
Michels' study. 
Table 7.04 Comparison of the % of the variant origins of the gastorduodenal artery 
Percentage 
Vessel origin In this study In Michels work p-value 
Right hepatic artery 5A% 7^0% 049 
Left hepatic artery 1.4% 11.0% 0.00001 < 0.05 
Coeliac axis 0.4% 1.5% 0.20 
In Michels' work, the percentage of a gastroduodenal arising from the left 
hepatic is significantly higher than that obtained in this study. The explanation of 
this big difference is beyond the scope of this study. 
In the context of this study, the way the variant vessels influence the 
endovascular treatment procedure is the main concern. To know the exact 
position of the origin of the gastroduodenal artery is to avoid introducing 
radioactive drug to the stomach via the gastroduodenal artery during 90Y-SIR 
treatment procedure. For the 'normal' origin of the gastroduodenal, the 'Type I-a 
endovascular procedure can be applied. The catheter placement is shown in 
figure 7.01 with infusion site at the proper hepatic provided that the entire hepatic 
arterial supply is from the proper hepatic artery. Otherwise, modifications have 




When the gastroduodenal artery arises £com the right or the left hepatic artery, 
generally the 'Type I-b endovascular treatment procedure can be applied. At 
least two infusions of the 90Y microspheres, one at the right hepatic and the other 
at the left hepatic, are to be given and the infusion sites are to be distal to the 
branching off of the gastroduodenal from either the right or the left hepatic 
artery. Figure 7.15 figure 7.16, figures 7.17a & 7.17b demonstrate the 
theoretically best infusion sites. 
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Figure 7.16 Catheterplacement for 90Y delivery for 'GD fr RH 
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Figure 7.17a Catheterplacement for 90Y delivery for ‘GDfr LH' 
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Figure 7.17b Catheterplacement for 90Y delivery for (GD fr LH' 
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7.9 The right gastric artery 
The varied mode of the origin of the right gastric is due to the varied mode in 
which the hepatic artery gives off its main branches. Most commonly, the right 
gastric arises from the proper hepatic artery. (Michels, 1955) In this study, 42% 
of the individuals have the right gastric artery originating from the proper hepatic 
artery. Obviously, all other variants amount to 58% which means that more than 
half of the individuals have variant right gastric artery. This seems to be the artery 
with the most variable origin and as the capillary bed is of great concern this 
artery will be the most likely to cause anxiety during SIR. Due to different 
method of classification, the available percentages for comparison are listed in 
table 7.05. 
Table 7.05 Comparison of the % of the variant origins of the right gas trie artery 
Percentage 
Vessel origin In this study In Michels, work p-value 
Left hepatic artery 35.5% 40.5% 0.30 
Right hepatic artery 10.1% 5.5% 0.09 
Gastroduodenal artery 3.6% 8.0% 0.06 
Absent 2.2% 0% 0.03 < 0.05 
Middle hepatic artery 1.1% 5.0% 0.02 < 0.05 
A significant difference was observed in the percentage of a right gastric artery 
arising from the middle hepatic artery. The right gastric artery is small and 
characteristically filamentous with an average diameter of 2mm. The 2.2% absent 
right gastric artery in this study may be due to the small si2e of the right gastric 
artery. 
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In this context, the variant right gasttic artery can be divided into two groups. 
All variant origins which are proximal to the normal origin form one group. The 
other variant origins which are distal to the normal origin form another group. 
Figure 7.18, figure 7.19, and figure 7.20 are examples of the former group of 
variant right gastric artery. The type of endovascular treatment procedure is 
predominantly governed by the vascular presentation of the hepatic arteries. The 
variant right gastric in this group has no significant influence in this respect. 
For the latter group where the variant origin of the right gastric artery is distal 
to the normal origin, the influence on the endovascular procedure is described 
here. Usually, the 'Type I-b or the ‘Type II-b endovascular treatment procedure 
can be applied when 90Y-SIR treatment has to be given. Figure 7.21 shows a right 
gastric from the left hepatic and the 'Type I-b endovascular treatment method is 
applied with one infusion of radioactivity at the right hepatic and the other 
infusion at the left hepatic. Figure 7.22 shows a right gastric from the right 
hepatic and the ‘Type II-b method is applied with embolization of the right 
gastric artery preceded by infusion of the radioactivity at the proper hepatic. 
Figure 7.23 shows a right gastric from the bifurcation of the proper hepatic and 
the 'Type I-b method is most suitable with two infusions of the radioactivity at 
the right and the left hepatic arteries. 
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Figure 7.18 Catheterplacement for 90Y delivery for 'RGfr CH 
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Figure 7.21 Catheterplacement for 90Y delivery for 'KG fr LH' 
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Fimre 7.22 Catheterplacement for 90Y delivery for ^G fr RH 
Trace drawing 
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Figure 7.23 Catheterplacement for 90Y delivery for 'KG fr BIF of PH 
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7.10 The left gastric artery 
Classically the left gastric artery is the first branch of the coeliac axis, thus it is 
included in this study. The variant origins of the left gastric artery observed in 
this study include aorta and bifurcation of the coeliac axis. Sometimes the left 
gastric artery is absent. None of these variant origins have special influence on 
the 90Y-SIR treatment procedure as long as the left gastric origin is proximal to 
the infusion site. 
One odd pattern was observed in Michels' study where the left gastric artery 
took origin from a right hepatic artery (figure 7.24). If endovascular treatment 
procedure were prescribed, modification had to be in such a way that the infusion 
should be distal to the origin of the anomalous left gastric artery. 
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Figure 7.24 Ijeft gastric originating from the right hepatic arteiy 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive 
Atlas by ALA Michels) 
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7.11 The splenic artery 
The splenic artery stems from the coeliac axis according to anatomy text 
books. In this study 99.3% of the subjects have this normal presentation. 
Michels quoted that 82% splenic artery arose £com the coeliac via a 
hepatolienogastric trunk. This apparently very different result may be due to 
racial difference, difference in research method, difference in classification 
method or others. Figure 7.25a and figure 7.25b demonstrate one example of 
different classification. Michels classified the splenic artery shown in figure 7.25a 
as a branch from the common hepatic. While in this study, this splenic is defined 
to be stemming from the coeliac axis as illustrated in figure 7.25b. The difference 
of the two studies is not the main theme of this study, but is a good illustration of 
the difficulties of classification, particularly where a trifurcation is involved. 
Other variant origins of the splenic artery observed in the study are the aorta 
and the superior mesenteric artery. These variants do not have any significant 
influence on the endovascular treatment procedure of 9 0 Y-SIR. . 
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Fioure 7.25a Splenic artery originatingfrom the common hepatic artery 
(From Blood Supply and Anatomy of the Upper Abdominal Organs With a Descriptive 
Atlas MA. Michels) 
Yimre 7.25b . Splenic arterv ominatin^ from the coeliac axis 
(Modified from Blood Supply and Anatomy of the Upper Abdominal Organs With a 
Descriptive Atlas by N^A. Michels) 
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7.12 Comparison with the golden classics 
Percentages observed in this study and percentages quoted from Michels were 
compared. There were only 25 pairs of values for comparison. The Chi-square 
test was used to test 13 pairs of the values and the other 12 pairs was tested with 
the Fishers' Exact Test since the expected cell frequency of these 12 pairs were < 
5. The p-values obtained were listed in Appendix VIII. There were seven p-
values which were less than 0.05. The corresponding seven pairs of percentages 
differed significantly and all the seven percentages from Michels' work were 
greater than that observed in this study. These seven variants were, right hepatic 
from superior mesenteric, accessory right hepatic from superior mesenteric, right 
hepatic from aorta, accessory left hepatic from left gastric, left hepatic from 
superior mesenteric, gastroduodenal from left hepatic, and right gastric from 
middle hepatic. The comparisons of these seven variants were shown in table 
7.06. 
Michels speculated a few causative factors for arterial variations, viz : 
• Variations in constitutional inheritance of which the anatomists know 
practically nothing for the body of the father or the mother of the 
body studied is never dissected. 
• Variations of evolution, i.e. atavistic remnants, of either a progressive 
or a regressive nature. This is impossible route for the human species 
because of lack of material. 
• Variations in hemodynamic potential, the type and the intensity of 
activity of a given organ and its rate of growth determining the 
constitution and the distribution of the arterial pattern (Thoma, Mall). 
• Variations of racial differences. 
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• Ontogenetic developmental peculiarities. The patterns of the arteries 
are determined by internal and external factors. For the coeliac axis 
and the superior mesenteric artery, developmental peculiarities would 
be correlated with the followings: 
1. variations in the degree and the site of gut rotation, 
2. persistence of differently interrupted sections of the primitive roots 
of the omphalomesenteric arteries and their longitudinal 
anastomoses (Tandler, 1904), 
3. variations in the rate and the manner of the cephalocaudad 
migration of the primitive gut arteries, as first claimed by Mall in 
1891. 
Of the speculated causative factors, racial difference might explain the 
difference observed in the two studies. Despite the fact that the percentages 
quoted from Michels are greater than that obtained in this study, the conclusion 
that 'arterial variations of the coeliac axis is more extensive in European than in 
Hong Kong Chinese' cannot be made since differences in the classification 
method, the method of research, the objectives of the research and the point of 
view of the researchers are there to invalidate this conclusion. The main 
difference of the two researches are tabulated in table 7.07. 
However regardless the arteries in which there is no disagreement in 
classification, and technical aspects of visualization or demonstration of the artery 
are unlikely to lead to significant misses there does seem to be sufficient grounds 
to state that there is a racial difference. This is not only of interest from a purely 
anthropological point of view but as has been amply demonstrated, is of great 
medical importance. 
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Table 7.06 P-values of the seven 'different' variants, as compared with Michels 
Vessel Vessel % from % from p-value 
origin this study Michels 
"RH SMA 4.7% 12.5% 0 0 0 3 ~ < 0 . 0 5 
ACC RH SMA 1.1% 4.5% 0.042 < 0.05 
RH Ao 0% 2.0% 0.031 < 0.05 
ACC LH LG 4.0% 11.5% 0.003 <0.05 
LH SMA 0% 2.5% 0.013 < 0.05 
GD LH 1.4% 11.0% 0.00001 < 0.05 
RG MH 1.1% 5.0% 0.021 < 0.05 
Table 7.07 Difference of the two researches, Michels and this study 
Michels study This study 
(Michels, 1955) 
Classification : Variants were grouped into Counts of individual variant origin 
method types and counts obtained for of vessels were obtained 
statistical study 
Research : Vascular patterns were obtained Vascular patterns were obtained 
method from dissection of cadavers from digital subtracted arteriograms 
Research : To provide a comprehensive To establish percentages of 
objectives atlas of vascular variants for individual variant origin and to find 
surgeons the influence of the variants on the 
SIR procedure 
Point of view : From the point of view of an From the point of view of a 
anatomist radiological interventionist 
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7.13 Comparison of subjects with HCC and without HCC 
In the study, there were 166 subjects with HCC and 110 subjects with other 
upper abdominal lesions without HCC. The Chi-square and Fishers Exact Tests 
were used to test the two groups for any statistical significance. All the p-values 
obtained are greater than 0.05 and all the p-values are listed in Appendix XIV. 
This implies that the group with HCC and the group without HCC do not differ 
significantly in arterial variations of the coeliac axis and its branches. Therefore 
the HCC group were not a selected sample with regards the study of anatomy and 
anatomical variants and conversely that there was no predilection to developing 
HCC as a result of particular anatomical arterial pathways. 
7-50 
Discussion Comparison, male & female 
7.14 Comparison of the male group and the female group 
Among the subjects recruited in the study, 197 were males and 79 were 
females. Chi-square and Fishers' Exact tests were used to test the two groups. 
All the p-values (see Appendix VX) are greater than 0.05 which means that 
statistically the two groups do not differ significantly. Thus, we can conclude 
that there is no gender difference in arterial variations of the coeliac axis and its 
branches. 
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CONCLUSIONS 
Trans-catheter 90Y-SIR therapy is a feasible treatment for inoperable HCC. 
(W.Y.Lau et al., in press). This 90Y-SIR therapy sheds new light on the difficult 
HCC and at same time brings the attention of the clinical oncologist and the 
radiological interventionist to the vascular anatomy of individual patient who is 
otherwise unsuitable for the treatment procedure. In this study, the vascular 
anatomy of the hepatic arterial supply is scrutinized. 72% of the population of the 
Hong Kong Chinese have at least one variant origin of the coeliac axis or its 
branches and 55.4% possess the classical pattern of the hepatic arterial supply. 
This high percentage of variation does not lower the feasibility for the treatment. 
With regard to the vascular anatomy, conscientious modification under expert 
hands, trans-catheter 90Y-SIR therapy is feasible theoretically in every individual 
needing it. 
When compared the Hong Kong Chinese with the Europeans (reference from 
Michels, 1955) apparently, frequency of arterial variations is higher in the 
Europeans than in the Hong Kong Chinese. 
From this study, there is no significant difference among the group with HCC 
and the group without HCC, and no gender difference in the arterial variations of 
the ten vessels studied. 
Conclusion 
Furthermore, when combining the three reasonings of: 
1. No significant difference was observed in the group with HCC and the 
group without HCC. 
2. No gender difference was observed. 
3. A well known fact that HCC is predominantly a 'male tumour'. 
One can conclude that no pattern or patterns of arterial flow predisposed to the 
development of HCC. 
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Appendix I 
Schematic diagram of histological anatomy of the liver 
Artery, vein and bite duct 
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A magnified transverse section of liver lobules 
(From Anatomy and Physiology by Ross & Wilson) 
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Schematic drawing showing the flow of blood and bile through a liver Inhiii 




In human fetus, organogenesis occurs between the second and the eighth 
week of gestation. During this period, the various organs, including the vascular 
system, are laid down, and differentiation begins. The primitive vascular supply is 
dual, with double aortas. There is a dorsal and a ventral arterial supply to the 
abdominal viscera. As the organs differentiate and the primitive circulation 
undergoes modifications, much of the double circulation is eliminated. The 
differing degrees of persistence of the dual circulation together with the variations 
in the caudal migration of the abdominal organs and rotation of the gut account 
for the manifestation of the many variations in the visceral circulation. 
Both dorsal aortas provide ventral segmental arteries to the viscera. These give 
rise to the vitelline arteries (figure 2.15). At about the fourth week, fusion of the 
ventral roots and reduction of the segmental arteries leads to the formation of the 
three main ventrally oriented vessels : the coeliac axis, the superior mesenteric and 
inferior mesenteric arteries. By about the seventh week, the coeliac artery forms 
from the tenth cephalic root then migrates from the cervical region caudally to 
the lower thoracic-upper lumbar level. The superior mesenteric artery forms 
from the thirteenth cephalic root near the T1-T3 segment and the inferior 
mesenteric artery originates from the twenty-first or twenty-second root. Both 
subsequently migrates caudally to their final positions. The eleventh and twelfth 
root regress. The ventral anastomosis connecting the ventral segmental roots 
usually disappear during differentiation (figure 2.16). . 
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Figure lib The 10th root forms the coeliac axis, the 13th forms the SMA. the 11th & 19th 
root and the ventral anastomosis regress 
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Appendix III 
Percentages of occurrence of the different types of coeliac axis, 
by Michels' study 
Types Percentages 
Type I. Hepatolienogastric Trunk 89% 
Type II. Hepatolienal Trunk 3.5% 
Type III. Hepatolienomesenteric Trunk 0.5% 
Type IV. Hepatogastric Trunk 1.5% 
Type V. Lienogastric Trunk 5.5% 
Type VI. Coeliacomesenteric Trunk 0% 
Type VII. Coeliacocolic Trunk 0% 
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Appendix IV 
Percentages of occurrence of the different types of 
the hepatic arterial blood supply, 
by Michels' study 
Types Percentages 
Type I. 55%""“' 
Type II 10% 
Type III 11% 
Type IV 1% 
TypeV 8% 
Type VI 7% 
Type VII 1% 
Type VIII 2% 
Type IX 4.5% 
Type X 0.5% 
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Comparison with Michels' study 
Vessel iPosslble™" %TbtaineT ^Tfrom™™ ^TTalu^ 
S t u d i e d j v e s s e l or igin from this study Michels' study From Chi-square test From Fished Exact test 
Ao 98.6% = I = = 
COELIAC SMA 1 . 1 % “ 
Ab ‘ 0.4% — 
Coeliac — 97.8% 
COMMON SMA — 1.4% 2.5% Q.31000 
HEPATIC Ao ‘ 0.7% 1.5% 0,35000 
LG 0.0%' 0.5% • 0.42000 
P R O P E R C H 80.4% "“ 
HEPATIC Ab ‘ 1 9 . 6 % ‘ ‘ 
PH “ 80.4% 
CH 14.1% — — 
SMA 4.7% 12.5% 0.00350. " “ 
RIGHT ACC fr SMA 1.T% 4.5% 0.04100 
HEPATIC ACC fr GD — 0.7% . — ~ 
Coeliac 0.7% 3.0% 0.06200 
ACC fr PH 0 .4% ~ 
Ao — 0-0% 2.0%' . 0 03100 
LG 0.0% 0.5% — 0,42000 
• RH 44.6% 45.0% 0,99937 
LH~ — 32.6% 45.0% 0.59000 
MIDDLE RH&LH — 14.9% “ 
HEPATIC Ab — 5 . 1 % “ 
PH “ 1.8% “ — 
CH 0.7% "‘ Z Z Z Z Z I I I I Z ~ I ~ 
GD — 0.4% -
PH 77.5% ‘ • 
CH 14.5% 
LG 7.2% 11.5% 0.15000' 
LEFT ACC fr LG “ 4 .0% 11.5% 0.00310 
HEPATIC Coeliac 0.4% 
^^mmmmmmmm^^mmmmm^m^^^^ mmmmmammmmmmmmmmimtmmmmm mmmmmmmmmmmrnmrnammmmmmmmmmmm -
Ab 0.4% 
SMA 0-0% 2.5% 0,01300 
Ao 0 . 0 % _ 1 . 5 % — — 0.07000 
CH ‘ 93.1% _ 
RH 5 . 1 % ' 7.0% 0.49000 
GASTRO- LH 1.4% 11.0% 0.00002 
DUODENAL Coeliac “ 0.4% 1.5% 0.20000 
SMA 0.0% 1.0% 0.18000 
MH “ 0 0% 1.0% 0.18000 
PH 42.0% 
LH “ 35.5% 40.5% 0.30000 
RH 10.1% 5.5% 0.09800 
RIGHT CH “ 4 .3% — 
GASTRIC GD 3.6% 8.0% 0.06200 
Ab 2 .2% — — 
MH 1.1% 5.0% 0.02100 ~ 
BlFofPH Q.7%" “ — 
BIF ofCH “ 0.4% . " " " " 
_ Coeliac 94.6% 90.0% 0.08810 ‘“ 
LEFT Ao 2 .2% “ 2 .5% — 0.52000 
GASTRIC BIF of Coeliac 1 8 % 
Ab “ 1-4% “ 
""Coeliac 99.3% “ — 
SPLENIC Ao 0-4% 
S M A ~ 0.4% 
Data not available 
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A p p e n d i x VI I I 
C o m p a r i s o n of t h e g r o u p w i t h H C C w i t h t h e g r o u p w i t h o u t H C C 
^ P o s s i b l e N o . N o . p_ v a l u e 
Vessel origin with HCC without HCC From Chi-square test iFrom Fisher's Exa t^esT 
| A o 1 6 3 | | I 0 .48 
• A C ^ 1 | 
COMMON Coeliac 162 108 "1 0 5 5 
_
, c
 ^ = = 1 = ^ = = ¾ 
PROPER CH 132 90 Q , 7 5 | I 
HEPATIC Ab 34 2 0 0 7 § | " H 
PH “ 131 91 Q.53I J 
CH 2 5 14 0 .71 j 
RIGHT SMA 9 ~4 0 .69 _ 
HEPATIC ACC fr SMA 2 j Q 6 5 
I F 1 [ 3 = = Z Z Z ^ | 4 
T" o 
^ R 50 0 .91 “ 
1 ^ = = ^ 1 = 1 = = 1 — — 
HEPATIC Ab 9 5 0 96 
RH 3 2 fTf i f i 
^ T T ^ 
5 5 1" o 
mmmmmmmmmmmmm ^^^m^mKmmmmmmm ^ W H ^ h h h m h h •HHHHH^^HMB m^^^mmrn^i^m^Kmmm U.DU 
CH 152 105 0 ^ 6 
TTT — | in"'— — 
GASTRO- RH ^ ± 028 
DUODENAL LH 3 ^ 0 4 8 
C o f a c 1 0 0 6 0 
— " 5 9 — — I — — ^ = = = 
^ 2 0 T 0 ^ 
R.OHT CH 6 1 — — - 0 ,33 
OASTR.C 5 5 5 - 5 ^ 
_ _ 
C ^ E 159 102 0 .41 
l e f t ^ 3 - = 4 h z z m i 
C B,FofCoe,iac 2 0 ^ 1 
——J 1 0 3 
SPLENIC AO 0 1 0 ,40 
•SMA 01 11 0 .40 
. . . . . , , 
••… Not applicable 
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Appendix IX 
Comparison of the male and female group 
^ P o s s i b l e |No. of No. of p- value 
V e s s e l o r i g i n |Male subject Female subject From Chi-square test |From Fisher's ExacTte^T" 
Ao — 193 79 0.26 
COELIAC SMA — 3 0 “ 0^36 
Ab 1 0 0 71 
COMMON Coeliac 192 78 :. :,?...?. . • q.45 
HEPATIC SMA 3 ~T ^ 0^68 
__________ Ao 2 0 0.51 
PROPER CH 158 64 0.99 
HEPATIC Ab — 39 15 0 9 9 
PH
 " 157 65 0,75 
CH~ — 29 ~ 10 0.8 
RIGHT SMA 9 ~ " 0^54 
HEPATIC ACC fr SMA 1_ ~2 "" Q2 
ACC fr GD 1 ~ 0 4 9 
Coeliac 2 0 0.51 
ACC fr PH 1 0 o 71 
RH~ — 89 ~ 33 _ 0.7 • _ 
LH 68 22 0,35 
MIDDLE RH & LH 24 17 Q.Q7 "“ 
HEPATIC Ab — ~ 9 5 0^37 
I Z Z H T 0:56 
CH 1 1 0 4 9 
GD 0 Q"51 
PH 153 ~ 0,99 
CH — 32 — 8 0.26 _ 
LEFT LG — 12 ~8 0 3 6 
HEPATIC ACC fr LG 5 6 0.06 
Coeliac — 0 0.71 
Ab — 0 ~T 029 
CH 180 77 0.12 
GASTRO- RH 12 2 “ 0~18 
DUODENAL LH ~ £ 0 0 2 6 
Coeliac 0 0.71 
PH 86 30 0.47 
LH 67 31 0.5 
RH 22 6 0.5 
RIGHT CH 8 4 — 0,47 
GASTRIC GD “ 8 2 “ 0^2 
Ab 3 3 0.23 
MH 2 1 0,64 
BIF of PH 0 2 0^8 
" "
 r i
 . . • .ii i i I ' 
B I F o f C H
 1 1 071 
Coeliac 186 75 0 5 6 
LEFT Ao — 3 3 — 0.23 
GASTRIC BIF of Coeliac 4 1 0.56 
Ab " " “ 4 0 0,26 
Coeliac 196 78 0.49 
SPLENIC Ao 0 1 0.29 
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